Molecular genetics of resilience by Rodrigues da Silva Zêzere, Inês
2016 
UNIVERSIDADE DE LISBOA 
FACULDADE DE CIÊNCIAS 
DEPARTAMENTO DE BIOLOGIA VEGETAL 
 
 
 
 
 
 
Molecular Genetics of Resilience 
 
 
 
 
Inês Rodrigues da Silva Zêzere 
 
 
 
Mestrado em Biologia Molecular e Genética   
  
 
Dissertação orientada por: 
Dra. Astrid Moura Vicente 
 
2016 
UNIVERSIDADE DE LISBOA 
FACULDADE DE CIÊNCIAS 
DEPARTAMENTO DE BIOLOGIA VEGETAL 
 
 
 
 
 
 
Molecular Genetics of Resilience 
 
 
 
 
Inês Rodrigues da Silva Zêzere 
 
 
 
Mestrado em Biologia Molecular e Genética   
  
 
Dissertação orientada por: 
Dra. Astrid Moura Vicente 
2016 
ACKNOWLEDGMENTS 
First and foremost, I want to thank my supervisor Dra. Astrid Moura Vicente for accepting me 
in the Neurogenetics and Mental Health group at the National Institute of Health Dr. Ricardo Jorge, 
giving me the opportunity to work in the field that I always wanted to. I want to thank the whole 
Health Promotion Department who welcomed me this past year and made me feel right at home, 
but specially the Neurogenetics and Mental Health group, who always encouraged me and never 
failed to help me when I needed. 
This work would not have been possible without Dra. Maria João Heitor, who provided the 
population in study and the psychosocial data used. 
I want to thank João Costa, from the Instituto Gulbenkian de Ciência, for all the help regarding 
the Sequenom MassARRAY. 
To Cláudia Branco, for all her help with the Arlequin software, even at a distance. 
To professor Lisete and Cláudia Mendes, who had the patience to explain statistics to a 
biologist, for their help and availability. 
To Carla Feliciano, for all the help in the lab, but mainly for all the patience and friendship 
throughout this year. 
A special thank you to Marta, Célia, Alexandra and João, not only for the coffees and jokes 
shared, but mainly for the friendship and for making my days much more special. 
To Miguel Ramos, whose teachings I still carry to this day. 
I want to thank my family, but specially my parents and my brother Ricardo, for the 
unconditional love and support. For all the times they pretended to understand what I was talking 
about and for giving me strength when I had none. 
A big thank you to Francisco, that despite all these years, never doubted me and still has the 
patience to endure all my craziness. For always listening no matter the time, the place or the subject. 
To my friends, new or old, here or far away, whose support never wavered, whose friendship 
was always available no matter what. I thank each and every person that ever had to hear me say 
the words “I cannot do this”. We did it.
Molecular Genetics of Resilience 
 
I 
 
TABLE OF CONTENTS 
List of Figures ..................................................................................................................................... III 
List of Tables ........................................................................................................................................ V 
Resumo Alargado ............................................................................................................................... VI 
Abstract ............................................................................................................................................... X 
Abbreviations ..................................................................................................................................... XI 
1 Introduction ................................................................................................................................ 1 
1.1 Genetics in mental health, psychiatric traits and resilience ............................................... 1 
1.2 The stress response ............................................................................................................. 2 
1.3 The HPA axis ........................................................................................................................ 3 
1.3.1 FKBP5 gene .................................................................................................................. 4 
1.3.2 CRHR1 gene ................................................................................................................. 5 
1.3.3 BDNF gene ................................................................................................................... 5 
1.3.4 OXTR gene ................................................................................................................... 5 
1.3.5 NPY gene ..................................................................................................................... 5 
1.4 Noradrenergic and sympathetic nervous system ............................................................... 6 
1.4.1 COMT gene .................................................................................................................. 7 
1.4.2 MAOA gene ................................................................................................................. 7 
1.5 The dopaminergic and serotonergic systems ..................................................................... 8 
1.5.1 SLC6A4 gene ................................................................................................................ 9 
1.5.2 SLC6A3 gene ................................................................................................................ 9 
1.5.3 DRD4 gene ................................................................................................................... 9 
1.6 The “Impact Assessment on Employment Strategies for Health - biopsychosocial 
determinants in employment” Project ......................................................................................... 10 
2 Objectives .................................................................................................................................. 11 
3 Material and Methods............................................................................................................... 12 
3.1 Population in study ........................................................................................................... 12 
3.2 Bibliographic revision ........................................................................................................ 13 
3.3 Sample preparation ........................................................................................................... 13 
3.4 SNP Genotyping ................................................................................................................. 13 
Molecular Genetics of Resilience 
 
II 
 
3.4.1 Sequenom MassARRAY ............................................................................................. 14 
3.4.2 Sanger Sequencing .................................................................................................... 14 
3.4.3 TaqMan® 5-nuclease assay ....................................................................................... 15 
3.5 VNTR Genotyping .............................................................................................................. 16 
3.5.1 SLC6A3 VNTR ............................................................................................................. 16 
3.5.2 DRD4 VNTR ................................................................................................................ 16 
3.5.3 MAOA VNTR .............................................................................................................. 17 
3.5.4 5HTTLPR VNTR ........................................................................................................... 17 
3.6 Quality Control Analysis .................................................................................................... 17 
3.7 Statistical Analysis ............................................................................................................. 18 
4 Results ....................................................................................................................................... 19 
4.1 Bibliographical review ....................................................................................................... 19 
4.2 Quality Control Analysis .................................................................................................... 20 
4.3 Statistical analysis.............................................................................................................. 22 
5 Discussion .................................................................................................................................. 25 
6 Conclusions and future perspectives ........................................................................................ 29 
7 References ................................................................................................................................. 30 
8 Supplementary Material .............................................................................................................. i 
 
  
Molecular Genetics of Resilience 
 
III 
 
LIST OF FIGURES 
Fig. 1 - The hypothalamic-pituitary-adrenal (HPA) axis. Upon a stressful situation, the 
paraventricular nucleus (PVN) of the hypothalamus releases corticotrophin-releasing hormone 
(CRH) and arginine vasopressin (AVP), which stimulate the pituitary to produce 
adrenocorticotropic hormone (ACTH), which in turn stimulates the release of glucocorticoids 
from the adrenal cortex, allowing an adequate response. This system is under the inhibitory 
control of the hippocampus and a sensible negative feedback system, as well as the stimulatory 
control of the amygdala; (+) – stimulation; (-) – inhibition. Adapted from Hyman, 2009 [11]. . 4 
Fig. 2 - (A) Projection sites of the locus coeruleus; (B) – Sympathetic nervous system pathway. (A) 
The locus coeruleus releases norepinephrine to its projection sites, namely the amygdala, 
prefrontal cortex and hippocampus. (B)  Upon a stressful stimulus, the preganglionic 
sympathetic neurons are activated and lead to the release of norepinephrine and epinephrine 
in the blood stream by the postganglionic neurons and the medulla of the adrenal glands, 
respectively. Adapted from (A) Rosenzweig, M. R., Breedlove, S.M., & Watson, n. V. (2005)[54], 
(B) Marieb, E.N., & Hoehn, K. (2013)[56]. ................................................................................... 7 
Fig. 3 - Dopaminergic and serotonergic projections. The dopaminergic neurons of the ventral 
tegmental area (VTA) send projections to the prefrontal cortex, amygdala, hippocampus and 
the nucleus accumbens. The serotonergic neurons located in the raphe nucleus project to 
nearly all parts of the central nervous system (CNS), namely the prefrontal cortex, striatum and 
substantia nigra; blue pathway – dopaminergic pathway; red pathway – serotonergic pathway; 
Adapted from: Blamb, Image ID: 329843900 via shutterstock.com [71]. .................................. 9 
Fig. 4 - Examples of genotyping results obtained with (A) Sequenom MassARRAY (B) TaqMan 5-
nuclease assay. (A) – Genotypes obtained for the rs9470080 polymorphism using Sequenom 
MassARRAY; Orange – TT genotype; green – CT genotype; blue – CC genotype. (B) – Genotypes 
obtained for the rs27072 polymorphism using TaqMan 5’-nuclease assay; blue – TT genotype; 
green – CT genotype; red – CC genotype. ................................................................................. 20 
Fig. 5 - Genotype pattern for the 40 bp SLC6A3 VNTR. Lanes 4, 6, 7, 8, 10, 11, 14 and 16 are 
homozygous for the 10 repetition allele (480 bp), lane 5 is homozygous for the 9 repetition 
allele (440 bp) and lanes 2, 3, 9, 12, 13, 15 and 17 are heterozygous for the 9 and 10 repetition 
allele; first and last lane labelled 100 bp as the molecular weight marker, all other lanes are 
identified with the ID of the individual. .................................................................................... 21 
Molecular Genetics of Resilience 
 
IV 
 
Fig. S1 - Genotype pattern for the 48 bp DRD4 VNTR. All individuals present the 4 repetition allele 
(540bp); first and last lane labelled 100 bp as the molecular weight marker, all other lanes are 
identified with the ID of the individual in question. ................................................................... ii 
Fig. S2 - Genotype pattern for (A) – 23 bp 5HTTLPR VNTR and (B) – 30 bp MAOA VNTR. (A) – lane 
4, 6 and 9 are presumably homozygous for the 16 repetition allele (419 bp), lane 2, 3, 7 and 8 
are the presumed heterozygous for the 16 and 14 repetition allele (419 and 375 bp 
respectively) where the artifact is noticeable; (B) – lane 3 is presumably homozygous for the 3 
repetition allele (350 bp), lane 4, 6, 7 and 9 are presumably homozygous for the 4 repetition 
allele (380 bp), lane 2 and 8 are the presumed heterozygous for the 3 and 4 repetition allele 
(350 bp and 380 bp respectively) where the artifact is noticeable; first and last lane labelled 
100 bp as the molecular weight marker, all other lanes are identified with the ID of the 
individual in question. ................................................................................................................. ii 
 
 
  
Molecular Genetics of Resilience 
 
V 
 
LIST OF TABLES 
Table 1 - Selected genes and polymorphisms ................................................................................... 19 
Table 2 - Selected tag SNPs for the MAOA and BDNF genes ............................................................ 20 
Table 3 - Demographic measures and univariate analysis results for the parameters in study ....... 23 
Table 4 - Multivariate genotypic and allelica analysis results for the polymorphisms associated with 
CD-RISC 10 scores ...................................................................................................................... 24 
Table S1 -  Quality control results for all polymorphisms genotyped .................................................. i 
Table S2 - Univariate genotypic, haplotypic and allelic regression analysis results between the 
molecular markers and CD-RISC 10 scores .................................................................................iii 
Table S3 - Multivariate genotypic, haplotypic and allelic regression analysis results for the remaining 
markers with the CD-RISC 10 scores ........................................................................................... v 
 
 
 
 
 
 
 
 
 
 
 
  
Molecular Genetics of Resilience 
 
VI 
 
RESUMO ALARGADO 
 
 Resiliência é a capacidade de ultrapassar situações de stress e adversidade de modo 
adaptativo, mantendo um funcionamento psicológico e físico normal. Como característica 
intrínseca, a resiliência é influenciada por variáveis externas, como a experiência pessoal e o suporte 
social, mas também por fatores genéticos que conferem suscetibilidade ou resistência, revelando 
assim a enorme complexidade por detrás da genética das variações comportamentais e doenças do 
foro psicológico. 
 Embora os mecanismos subjacentes à resiliência ainda não estejam bem definidos, tudo 
indica que a predisposição genética do indivíduo juntamente com a interação com fatores 
ambientais modulam os sistemas neurológicos e neuroquímicos, nomeadamente o eixo 
hipotálamo-pituitária-adrenal (HPA), o sistema noradrenérgico e os sistemas serotonérgico e 
dopaminérgico, desta forma levando à variabilidade na resiliência ao stress. Deste modo, a maioria 
dos estudos de associação genética relativos a este traço psicológico têm recaído sobre os genes 
relacionados com estes sistemas. 
 O eixo HPA é o coordenador central dos sistemas neuroendócrinos de resposta ao stress, 
tal como o sistema nervoso central, o sistema metabólico e o sistema imunitário, através de uma 
resposta em cascata iniciada no hipotálamo que liberta a hormona libertadora de corticotrofina 
(CRH), que estimula a libertação da hormona adrenocorticotropica (ACTH) por parte da pituitária, e 
que consequentemente estimula o córtex adrenal a libertar glucocorticoides para o sistema 
circulatório, proporcionando assim uma resposta adequado ao estímulo. Genes como FKBP5 e 
CRHR1 influenciam diretamente o eixo HPA ao regular a atividade dos glucocorticoides e de CRH, 
respetivamente. Por outro lado, genes como BDNF, OXTR e NPY atuam sobre estruturas reguladoras 
deste eixo, tal como o hipotálamo e a amígdala. 
 O sistema nervoso central assim como o sistema nervoso simpático são responsáveis 
pela libertação de epinefrina e norepinefrina, estando envolvidos na regulação dos processos 
emocionais. Os genes MAOA e COMT são genes responsáveis pela inativação destes 
neurotransmissores, e como tal estão bastante envolvidos no bom funcionamento do sistema 
nervoso central e do sistema nervoso simpático. 
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  Por outro lado, os sistemas dopaminérgico e serotonérgico modulam a atividade do eixo 
HPA ao projetar tanto para as estruturas que o constituem como para as que o regulam, estando 
estes sistemas bastante envolvidos no processamento emocional e no controlo do estado de humor. 
O gene SLC6A4 é um importante determinante da neurotransmissão da serotonina ao regular o seu 
término e recaptação, enquanto que o gene SLC6A3 é responsável pela recaptação da dopamina, 
regulando assim a sua neurotransmissão. Já o gene DRD4 apresenta elevada variabilidade e codifica 
para um recetor de dopamina com expressão em diversas áreas do cérebro, tendo sido implicado 
em diversos distúrbios psiquiátricos. 
 O estudo da resiliência e dos mecanismos a ela associados é de enorme relevância, não 
só porque permitem retratar e compreender melhor a genética dos traços de personalidade e dos 
distúrbios psiquiátricos, mas também porque a identificação de genes candidatos poderá permitir 
o desenvolvimento de novos marcadores para exames médicos, e a identificação de fatores 
protetores poderá prevenir respostas inadaptadas ao stress e assim ajudar a promover a resiliência 
e a saúde mental.   
 Assim, este projeto visa compreender a genética molecular da resiliência, identificando 
os genes e marcadores moleculares que a ela poderão estar associados, assim como outros fatores 
externos que poderão influenciar este traço.  
 Para tal, selecionou-se os genes e polimorfismos com maior evidência de estarem 
associados à resiliência, assim como a distúrbios psiquiátricos, nomeadamente depressão e 
distúrbios de ansiedade, através de uma extensa revisão bibliográfica, e identificou-se o genótipo, 
para os marcadores moleculares e genes selecionados, da população em estudo, 261 indivíduos 
portugueses, cujos componentes psicossociais já tinham sido previamente avaliados, através da 
aplicação de um questionário que continha a escala de resiliência de Connor-Davidson, entre outras. 
Para a genotipagem foram utilizados diversos métodos de biologia molecular, nomeadamente 
Sequenom MassArray, uma tecnologia que permite a genotipagem por espetrometria de massa, e 
sequenciação por método de Sanger, nos casos em que a primeira genotipagem não foi clara. Foi 
também utilizado para um dos polimorfismos um TaqMan® 5- nuclease assay, uma tecnologia 
baseada na técnica de reação em cadeia da polimerase (PCR) em que a região flanqueadora do 
polimorfismo é amplificada na presença de sondas de fluorescência específicas, assim como PCR 
seguido de eletroforese em gel de agarose, para analisar os variable number of tandem repeats 
(VNTRs). De seguida, a inferência estatística permitiu avaliar a associação entre o genótipo dos 
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indivíduos e os valores de resiliência, tendo em consideração outros parâmetros que pudessem 
influenciar este traço. 
 Analisámos com sucesso 39 polimorfismos, após termos submetido todos os resultados 
obtidos pela genotipagem a um controlo de qualidade. Os polimorfismos excluídos da análise foram, 
portanto os que apresentavam um desvio do equilíbrio de Hardy-Weinberg e/ou os os genótipos 
dos indivíduos HapMap não correspondiam ao esperado, e como tal não passaram no controlo de 
qualidade. Os polimorfismos que passaram no controlo de qualidade, mas que se apresentaram 
como monomórficos também foram excluídos da análise, visto não serem uteis para um estudo de 
associação. Não nos foi possível genotipar com confiança os indivíduos para os VNTRs do gene 
MAOA e SLC6A4, devido a um artefacto visível no que se depreende ser os indivíduos 
heterozigóticos, possivelmente causado pelo “reannealing” de fragmentos complementares com 
sequências diferentes. 
 A análise estatística univariada revelou associações entre a existência de depressão e 
ansiedade e menor resiliência, enquanto que maiores níveis de educação, como estudos pós-
graduados e cursos profissionais, indicavam uma maior resiliência. A análise univariada também 
demonstrou a ausência de associação entre a resiliência e a idade, tomar comprimidos para dormir, 
o gênero e a tensão arterial. 
 As outras escalas aplicadas na componente psicossocial eram responsáveis por avaliar o 
suporte social, a felicidade subjetiva, o estado de saúde mental e a presença de sintomatologia física 
e psicológica associada a stress. A análise revelou que maiores níveis de felicidade subjetiva, de 
estado de saúde mental e a ausência de sintomatologia associada a stress sugeriam maior 
resiliência. Porém, verificou-se que menor suporte social estava correlacionado com maior 
resiliência, o que vai contra o esperado e poderá ser devido ao tamanho da amostra. 
De todos os genes avaliados neste estudo, a análise univariada detetou apenas uma 
associação entre a resiliência e um polimorfismo do gene MAOA. Porém a análise haplotípica 
envolvendo este polimorfismo não revelou qualquer associação, o que aponta para um falso 
positivo.  
Ao realizar uma análise multivariada, ficou evidente que emoções e humores positivos assim 
como a ausência de sintomatologia psicológica relacionada a stress moderam a resiliência, 
demonstrando como um pensamento positivo permite construir melhores mecanismos de defesa 
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contra situações adversas, assim como é elucidativo da importância de uma resposta biológica ao 
stress adequada e flexível, de modo a manter um funcionamento físico e psicológico normal em 
contexto de adversidade. 
A análise multivariada também revelou uma associação entre o polimorfismo rs53576 (G>A) 
pertencente ao gene OXTR, demonstrando que indivíduos que possuíam duas cópias do alelo 
considerado de risco (A) têm menor resiliência, deste modo indicando a influência deste gene no 
mecanismo biológico de resposta ao stress e na variabilidade deste traço. 
Por último, identificou-se também uma associação entre o alelo de risco (9 repetições) do 
VNTR do gene SLC6A3 e menor resiliência, o que vai de encontro a estudos anteriores que indicam 
que este alelo leva a uma menor atividade da proteína, afetando deste modo o mecanismo de 
resposta ao stress, e podendo assim causar variabilidade na capacidade de ultrapassar 
adversidades. É de denotar que na análise genotipíca, apenas obtivemos associação com o genótipo 
heterozigótico, e não para o genótipo homozigótico para o alelo de risco, e que apenas a análise 
alélica é que nos permite confirmar a associação entre o alelo de risco e o fenótipo de resiliência. 
Isto terá ocorrido devido à falta de representação deste genótipo na população em estudo.  
Este estudo apresenta algumas limitações, nomeadamente o tamanho da amostra, que se 
revelou pouco representativa em alguns casos. Deverá ter-se em conta que o pretendido era 
analisar o impacto de cada um dos marcadores em separado, e não obter um único modelo preditivo 
que explicasse os valores de resiliência, e assim não sentimos necessidade de corrigir os resultados 
aqui apresentados para testes múltiplos, que devem ser vistos como exploratórios. É de denotar 
também que a resiliência é um traço extremamente complexo e que não foi possível avaliar todos 
os genes envolvidos nos sistemas neurológicos e neuroquímicos nem todos os fatores ambientais 
que poderão influenciar a resiliência, e como tal os resultados descritos aqui poderão não se revelar 
verdade em estudos de maiores dimensões.  
Em conclusão e resumidamente, o presente trabalho fornece fortes evidências da influência 
da composição genética, bem como outras características pessoais, na resiliência. 
Palavras – chave: resiliência, distúrbios psiquiátricos, stress, genética, fatores ambientais 
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ABSTRACT 
Resilience is a personality trait defined as the capacity to adaptively overcome stress and 
adversity while maintaining normal psychological and physical functioning. The study of resilience 
is of great interest and promise as it can provide insight on the genetics that underlie some 
personality traits and psychiatric disorders, like post-traumatic stress disorder (PTSD) and help 
identify candidate genes that could potentially be used as markers for medical testing, as well as 
protective factors that can help promote resilience. Although the complex mechanisms that 
underlie resilient phenotypes are not yet fully understood, evidence suggests that an individual’s 
genetic make-up and the interaction with environmental factors shape the neurochemical and 
neurological systems, mainly the hypothalamus-pituitary-adrenal (HPA) axis, the noradrenergic 
system, and the serotonergic and dopaminergic systems, therefore modulating the variability in 
stress resilience. As such, the vast majority of the association studies relative to resilience have 
focused on genes linked to these systems. In this study, we genotyped 261 Portuguese individuals 
for genes and polymorphisms that had been formerly linked to resilience or psychiatric disorders 
and tested the results for association with the resilience scores previously obtained, considering as 
well other psychosocial characteristics. The analysis revealed an association between positive 
emotions and the absence of psychological symptomology associated to stress and higher resilience, 
which is demonstrative of the impact of a positive mind-set and a flexible biological stress response 
on resilience variability. After adjusting for all confounding non-genetic variables, it was also 
noticeable an association between the rs53576 (G>A) polymorphism of the OXTR gene, as well as 
the SLC6A3 40 bp VNTR and resilience, with the risk alleles of each polymorphism being associated 
with lower resilience, therefore indicating a functional impact of these variants on the stress 
response mechanism and demonstrating their influence on resilience variability. In conclusion, this 
study points to the influence of genetic factors as well as environmental factors on resilience, and 
the importance of studying these two components to truly understand this complex trait. 
Key words: resilience, psychiatric disorders, stress, genetics, environmental factors 
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1 INTRODUCTION 
 Most people at different points in their lives will experience distressing, if not debilitating, 
events but not everyone has the same reaction [1]. Individual differences have been reported in 
how people respond to trauma, with some people revealing a greater capacity to overcome 
adversity, whilst others are more vulnerable [1–3]. 
 Resilience can be defined as the capacity to adaptively overcome stress and adversity while 
maintaining normal psychological and physical functioning, and not merely as the absence of 
psychopathology [4,5]. Thus a resilient individual is one that has experienced a traumatic event and 
continues to demonstrate adaptive psychological and physiological stress responses [6]. As a 
personal characteristic, resilience is likely influenced by external variables, such as adequate social 
support, that reduces the risk of stress-related mental disorders by buffering the impact of stress 
[7,8]. 
 Understanding the impact of trauma and how resilience is developed and enhanced is 
therefore of great relevance in current times, in order to not only promote coping mechanisms but 
also mitigate maladaptive coping and stress response in psychiatric illnesses, such as depression and 
post-traumatic stress disorder (PTSD) [4,9,10]. 
1.1 GENETICS IN MENTAL HEALTH, PSYCHIATRIC TRAITS AND RESILIENCE 
It is well known that genetic factors contribute to practically almost every human disease, 
whether by conferring susceptibility, resistance or by influencing severity and progression, as 
alterations in the DNA sequence of genes may modify protein expression, which can impact 
biological functions. Regarding mental health, personality traits and psychiatric disorders, these are 
extremely complex traits resulting from the intricate wiring of the neurochemical and neurological 
systems, the interaction between multiple genes linked to these systems and the interplay between 
multiple genes and environmental factors [11,14]. 
 Character traits are considered to be acquired during development and influenced by 
sociocultural learning, with evidence indicating a heritable component. This suggests the influence 
of a genetic element in the individual variability of psychological traits. There are several 
neurological systems that are assumed to regulate personality, namely the dopamine, serotonin and 
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noradrenergic systems, and so the study of genes involved in these pathways is of an extreme 
promise for a better understanding of personality and personality disorders [14]. 
Resilience, as a personal characteristic, is likely mediated by several environmental factors, 
as well as genetic and neural mechanisms. Although the range of complex mechanisms that underlie 
resilient phenotypes is not yet fully understood, evidence suggests that an individual’s genetic 
make-up and the interaction with environmental factors shape the neurochemical and neurological 
systems, mainly the hypothalamus-pituitary-adrenal (HPA) axis, the noradrenergic system, and the 
serotonergic and dopaminergic systems, therefore modulating the variability in stress resilience [6].  
The study of resilience and the mechanisms that underlie this trait is of great interest, because 
not only can it provide insight on the genetics behind psychiatric disorders, like PTSD, depression or 
anxiety disorders, but the identification of candidate genes may provide a starting point for the 
development of new, useful markers for medical testing, and the identification of protective factors 
that can help promote resilience and help prevent maladaptive responses to trauma, as well as 
mitigate mental health issues [6,14,15]. 
The most common approach to identify the genetic variants underlying a certain phenotype 
is the genetic association approach, in which a group of unrelated individuals with a certain 
phenotype is compared for alleles or genotypes, in order to identify candidate genes or genome 
regions that contribute to disease [14,16]. Regarding resilience, the vast majority of these studies 
have fallen upon the genes involved in the neurochemical and neurological systems that underlie 
the stress response mechanism [6]. 
1.2 THE STRESS RESPONSE 
 The stress response is understood as the adaptive physiological and psychological 
processes activated whenever there is a discrepancy between what an organism is expecting and 
what really exists [17]. The stress response is not harmful in itself but, upon prolonged and 
demanding stressful situations, homeostasis can be threatened and health may be endangered, 
since stress can lead to alterations in several neurochemicals that modulate neural circuits, including 
those involved in the regulation of reward, fear conditioning and social behaviour [17,18]. 
A suitable stress response is of absolute necessity for sustained health in the face of 
adversities and for reducing mental health disturbances after exposure to severe adversities. The 
Molecular Genetics of Resilience 
3 
 
major neural systems responsible for the stress response are comprised by the HPA axis, the 
noradrenergic and sympathetic nervous system (SNS) and the dopaminergic and serotonergic 
neurotransmitter systems [5]. 
Resilience has thus been associated with the flexibility of the neurochemical stress response 
systems as well as the neuronal circuitry involved in the stress response. Therefore, it is possible 
that genetic make-up can influence resilience through impact on several neurochemical stress 
pathways [19]. 
1.3 THE HPA AXIS 
The HPA axis is the central coordinator of the mammalian neuroendocrine stress response 
systems and includes the paraventricular nucleus (PVN) of the hypothalamus, the anterior lobe of 
the pituitary gland, and an effector organ, the adrenal glands [20,21]. 
When exposed to stressful stimuli, neurons in the PVN of the hypothalamus release two 
neurohormones – corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) – into 
the blood vessels connecting the hypothalamus and the pituitary. Both these hormones stimulate 
the anterior pituitary gland to produce and secrete adrenocorticotropic hormone (ACTH) into the 
general circulation. In turn, the ACTH induces glucocorticoid synthesis and release from the cortex 
of the adrenal glands. Glucocorticoids modulate metabolism as well as immune and brain function, 
thereby orchestrating an adequate behavioural response to manage stress [21,22](Fig. 1).  
The HPA axis is carefully modulated through elaborate negative feedback systems designed 
to maintain predetermined hormone levels and homeostasis [5,22]. To this end, secretion of CRH, 
AVP and ACTH are in part controlled by sensitive feedback exerted by glucocorticoids at the level of 
the hippocampus, PVN and pituitary gland [22] (Fig. 1). 
The HPA axis is also under the inhibitory control of the hippocampus as well as the excitatory 
control of the amygdala [23]. The hippocampus is implicated in learning and long-term memory 
formation [2,24] and restrains PVN activity, as well as most aspects of the HPA axis, including the 
onset and termination of stress responses, through binding of glucocorticoids to hippocampal 
receptors [20,25,26] (Fig.1). 
In contrast, the amygdala, as a part of the limbic system, is associated with processing 
memories and emotional reactions and appears to be critical in activating the HPA axis in response 
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to cognitive-emotional challenge and threat [2,24]. Glucocorticoid occupation of the amygdala 
receptors can facilitate the activity of the HPA axis, often increasing CRH production within the 
amygdala [24] (Fig.1 ). 
Several genes have been known to have an effect on HPA axis, either by influencing the 
activity of the hormones involved in this system, like the FKBP5 and CRHR1 gene, or by impacting 
structures, namely the hippocampus and the amygdala, that regulate the HPA axis, as is the case of 
BDNF, NPY and OXTR gene. Due to their function and impact on biological systems, these genes have 
been associated not only with resilience but also with many psychiatric disorders, such as depression 
and PTSD [4,27]. 
 
 
 
 
 
 
 
Fig. 1 - The hypothalamic-pituitary-adrenal (HPA) axis. Upon a stressful situation, the paraventricular nucleus (PVN) of 
the hypothalamus releases corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP), which stimulate the 
pituitary to produce adrenocorticotropic hormone (ACTH), which in turn stimulates the release of glucocorticoids from 
the adrenal cortex, allowing an adequate response. This system is under the inhibitory control of the hippocampus and a 
sensible negative feedback system, as well as the stimulatory control of the amygdala; (+) – stimulation; (-) – inhibition. 
Adapted from Hyman, 2009 [11]. 
1.3.1 FKBP5 gene 
The correct function of glucocorticoid receptors (GR) is dependent of a large molecular 
complex, necessary for proper ligand binding, receptor activation and transcriptional regulation of 
target genes [28]. The FKBP5 gene encodes the FK506-binding protein 5 (FKBP5), a co-chaperone of 
heat shock protein 90 (hsp90), which binds to the GR. Upon ligand binding, FKBP5 allows the 
translocation into the nucleus where the complex regulates the expression of glucocorticoid-
responsive genes by functioning as a transcription factor [29,30]. 
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1.3.2 CRHR1 gene 
The corticotropin-releasing hormone receptor 1 gene (CRHR1) encodes the G-protein 
coupled type 1 CRH receptor (CRHR1) that acts as a key activator of the HPA axis, by binding to 
receptors that initiate the stress response [31–33]. In addition to its effects on the HPA axis, CRH 
activity at extra-hypothalamic regions is also thought to produce symptoms of anxiety and 
depression [34]. 
1.3.3 BDNF gene 
The BDNF gene encodes the brain-derived neurotrophic factor (BDNF), a member of the 
neurotrophin family of polypeptide growth factors that is widely expressed in the mammalian brain 
and has a crucial role in the regulation of hippocampal plasticity and learning processes dependent 
of this brain region [35–37]. BDNF activity contributes to various forms of emotional and cognitive 
learning, as well as spatial and contextual learning, and has been implicated in several psychiatric 
disorders, including depression, anxiety, and PTSD [35,36]. 
1.3.4 OXTR gene 
The OXTR gene encodes the oxytocin receptor (OXTR) by which the hormone oxytocin (OXT) 
exerts a range of effects throughout the body and brain, with central actions in the limbic system, 
the forebrain and the automatic centres of the brainstem [38,39]. OXT has widespread receptor-
mediated effects on behaviour and physiology, including modulation of HPA axis and amygdala 
reactivity, as well as attachment processes and social cognition [27,40,41].  
1.3.5 NPY gene 
 The NPY gene encodes the neuropeptide Y (NPY), a 36 amino-acid peptide highly conserved 
among species and with a broad distribution in the central nervous system (CNS) [42,43]. NPY plays 
a role in the regulation of numerous basic physiological functions, such as circadian rhythm, 
neuronal excitability, and addictions, as well as modulation of emotional responses to various 
stressors, and is thought to facilitate the containment of negative consequences following exposure 
to stress, therefore being recognized as a major neurochemical factor for post-traumatic resilience 
and recovery in humans [42,43].  
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1.4 NORADRENERGIC AND SYMPATHETIC NERVOUS SYSTEM 
Epinephrine and norepinephrine, of the catecholamine family, have a key role in stress 
response by being involved in the regulation of emotional processes, acting as a hormone or as a 
neurotransmitter. Their effects are mediated by adrenergic receptors located in several neurons 
and glial cells in the brain and they are released in the blood stream by the CNS, mainly the locus 
coeruleus (LC), the primary noradrenergic nucleus in the brain, as well as the SNS [17,44]. 
Upon a stressful situation, the activation of the noradrenergic system results in increased 
release of norepinephrine from the LC to its projection sites, which include the amygdala, prefrontal 
cortex and hippocampus, resulting in the inhibition of the prefrontal cortex, a structure implicated 
in planning complex cognitive behaviour, thereby favouring instinctive responses [5,45] (fig. 2A). 
The release of norepinephrine also plays a key role in the consolidation of negative emotional 
memories and additionally projects the amygdala to further stimulate its activation in a positive 
feedback fashion [45]. Thus, a hyper response of the noradrenergic system is usually associated with 
anxiety disorders and cardiovascular problems [46]. 
The primary role of SNS is establishing a “flight-or-fight” response upon a traumatic or 
stressful event, preparing the organism for action through the increase of circulating levels of 
epinephrine and norepinephrine, heart rate, peripheral vasoconstriction and energy mobilization. 
Stress exposure results in activation of preganglionic sympathetic neurons in the spinal cord, leading 
to the release of norepinephrine and epinephrine in the blood stream by the postganglionic neurons 
and the medulla of the adrenal glands, respectively [47] (fig. 2B). 
A hyper-responsive SNS can lead to a diminished biological response to stress due to the 
continuous stimulation of adrenergic receptors, therefore contributing to hypervigilance, fear, 
intrusive memories and increased risk for hypertension and cardiovascular disease [48,49]. Thus, 
resilient individuals are those able to maintain SNS activation within a window of adaptive elevation, 
which would be high enough to ensure an accurate response but no so high as to lead to incapacity, 
anxiety and fear [48]. 
 The COMT and MAOA genes have been tested as candidate genes for psychiatric disorders, 
such as affective disorders and attention deficit hyperactivity disorder (ADHD), as they have been 
associated with the good functioning of the noradrenergic and sympathetic nervous systems, due 
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to their regulatory role on  the neurotransmission of epinephrine, norepinephrine, among others 
neurotransmitters [50–53]. 
 
 
 
 
 
 
Fig. 2 - (A) Projection sites of the locus coeruleus; (B) – Sympathetic nervous system pathway. (A) The locus coeruleus 
releases norepinephrine to its projection sites, namely the amygdala, prefrontal cortex and hippocampus. (B)  Upon a 
stressful stimulus, the preganglionic sympathetic neurons are activated and lead to the release of norepinephrine and 
epinephrine in the blood stream by the postganglionic neurons and the medulla of the adrenal glands, respectively. 
Adapted from (A) Rosenzweig, M. R., Breedlove, S.M., & Watson, n. V. (2005)[54], (B) Marieb, E.N., & Hoehn, K. (2013)[56]. 
1.4.1 COMT gene 
The COMT gene encodes the catechol O-methyltransferase (COMT) enzyme involved in the 
inactivation of the catecholamines, including dopamine, epinephrine, and norepinephrine, and is 
the main factor controlling dopamine levels in the prefrontal cortex [51,52,55]. A reduction in 
enzyme activity leads to a slower catalysis of catecholamines, and as such it has been implicated in 
a number of psychiatric disorders, including psychotic, affective and anxiety disorders [51,52,55,57]. 
1.4.2 MAOA gene  
 The MAOA gene, located in the X chromosome, encodes the monoamine oxidase A (MAOA) 
enzyme, responsible for breaking down neurotransmitters, such as norepinephrine, serotonin, and 
dopamine, leading to their inactivation [50,58]. Due to its important role in the serotonergic and 
dopaminergic pathways, this gene has been implicated in various mental health conditions in both 
children and adults, including major depressive disorder, autism spectrum disorders, aggressive 
behaviours, panic disorder, and ADHD [53]. 
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1.5 THE DOPAMINERGIC AND SEROTONERGIC SYSTEMS 
The stress-responsive mesocorticolimbic dopaminergic system has an important role in the 
control of mood, since dopamine is one of the most predominant catecholamine neurotransmitters 
in the brain, capable of modulating the mechanisms underlying states of fear and anxiety [59,60]. 
Both the mesocortical and mesolimbic components of the dopaminergic systems are 
innervated by PVN CRH neurons and the LC - noradrenergic system and are therefore activated 
during stress [61]. The mesocorticolimbic system consists of dopaminergic neurons of the ventral 
tegmental area (VTA), which sends projections to the nucleus accumbens as well as the limbic 
regions, including the amygdala, hippocampus and prefrontal cortex, and is involved in anticipatory 
phenomena and cognitive functions, as well as being associated with inhibition of the stress system 
[61,62] (fig. 3). 
Serotonin is a neurotransmitter capable of exerting a wide influence over several brain 
functions. In the brain it is synthesized exclusively in serotonergic neurons located in the raphe 
nucleus of the brainstem and project to nearly all parts of the CNS, thereby making the serotonergic 
network one of the most diffused neurochemical systems in the brain [17,63,64] (fig. 3). The 
widespread distribution of serotonergic fibres accounts for the large variety of functions that are 
modulated by serotonin, including thermoregulation, emotional processing, and cardiovascular 
function [17,63,64]. 
Serotonin plays a regulatory role on stress-induced HPA activity through direct actions at 
the hypothalamic, pituitary and adrenal level, influencing the secretion of glucocorticoids in a 
stressor-dependent manner [63,65,66] 
Genes like SLC6A4 and SLC6A3 are main regulators of the neurotransmission of dopamine 
and serotonin, and have been known to influence the functioning of the dopaminergic and 
serotonergic systems and lead to variability in stress sensitivity. On the other hand, the DRD4 gene 
has been known to be highly polymorphic and have a wide area of expression in the brain, and so 
has been linked to several neuropsychiatric disorders [67–69]. These genes have also been targets 
for drugs used for psychiatric stress-related disorders [70]. 
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Fig. 3 - Dopaminergic and serotonergic projections. The dopaminergic neurons of the ventral tegmental area (VTA) send 
projections to the prefrontal cortex, amygdala, hippocampus and the nucleus accumbens. The serotonergic neurons 
located in the raphe nucleus project to nearly all parts of the central nervous system (CNS), namely the prefrontal cortex, 
striatum and substantia nigra; blue pathway – dopaminergic pathway; red pathway – serotonergic pathway; Adapted 
from: Blamb, Image ID: 329843900 via shutterstock.com [71]. 
1.5.1 SLC6A4 gene 
The serotonin transporter gene (SLC6A4) encodes the serotonin transporter protein (5-HTT), 
responsible for terminating serotonergic neurotransmission and recycling supplies of serotonin 
[67,72]. The serotonin transporter-linked promoter region (5HTTLPR) influences its transcriptional 
activity, and has been known to moderate psychopathological reactions to stressful experiences, 
usually being associated with differences in the susceptibility to major depression or depressive 
symptoms [7,73,74] 
1.5.2 SLC6A3 gene 
The solute carrier family 6 member 3 (SLC6A3)  gene encodes a sodium-dependent 
dopamine transporter (DAT) responsible for the reuptake of dopamine into the presynaptic 
terminals, therefore playing a key role in the regulation of dopaminergic neurotransmission 
[68,75,76]. Alterations in gene expression have an impact on the dopamine transporter function, 
and has thus been associated to PTSD and ADHD [76,77]. 
1.5.3 DRD4 gene 
The human dopamine receptor D4 gene (DRD4) is a highly polymorphic gene with great 
impact in susceptibility to environmental influences [69,78,80].  The DRD4 protein is expressed in 
several brain regions, with a high level of expression in the prefrontal cortex, and therefore has 
received particular attention because of its possible role in neuropsychiatric disorders [79,81]. 
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1.6 THE “IMPACT ASSESSMENT ON EMPLOYMENT STRATEGIES FOR HEALTH - BIOPSYCHOSOCIAL 
DETERMINANTS IN EMPLOYMENT” PROJECT 
The “Impact Assessment on Employment Strategies for Health – biopsychosocial determinants 
in employment” is a project led by Dra. Maria João Heitor, director of the Department of Psychiatry 
and Mental Health of the Beatriz Ângelo Hospital, in a partnership between the Institute of 
Preventive Medicine (IMP) of the Faculty of Medicine of Lisbon (FML) / University of Lisbon (UL), the 
National Institute of Health Doctor Ricardo Jorge, IP (INSA) and the High Commissioner for Health 
(ACS). 
 In this project, an observational study was conducted with a sample of Portuguese workers by 
applying a psychosocial questionnaire, collecting anthropometric data and blood pressures 
measurements, as well as blood collections to assess biological parameters. This study was 
performed to have a better understanding of the work related psychosocial and biological factors 
that influence the spectrum between health and disease, so that ultimately interventions for health 
promotion can be developed and applied in the work context [82,83]. As such, the study here 
presented regarding the molecular genetics of resilience falls within the biological factors studied in 
this project. 
Since the “Impact Assessment on Employment Strategies for Health – biopsychosocial 
determinants in employment” project studied a population in the context of work environment, 
where they are frequently exposed to stressful situations, it constitutes a good representation of 
resilience in the work place, and so can be considered a good model to assess genetic and 
environmental associations with resilience. 
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2 OBJECTIVES 
 Resilience is a personal characteristic described as the capacity to overcome situations 
of stress that would otherwise compromise the psychological and physical well-being, and so is likely 
influenced by environmental and genetic factors [4,5,8,84]. The study of resilience is of great 
importance, not only to have a better understanding of related psychiatric illness, such as post-
traumatic stress disorder (PTSD), but also to promote better coping mechanisms and mitigate 
maladaptive responses [4,9,10]. 
 With this study, we expect to further understand the influence of genetic variants in the 
response to stressful stimulus in the work environment. We also intended to evaluate how certain 
factors, such as gender, age, marital status, as well as social support and a positive mind-set, 
integrated with genetic factors, can modulate how one reacts in a context of adversity. Therefore, 
the main aims of this work were the identification of genetic markers, as well as other personal 
characteristics and external factors, that might have an impact on resilience.   
 For this purpose, we genotyped a population of 261 Portuguese individuals, for which 
we already had values of resilience and other socio-demographic, lifestyle and clinical parameters 
in study, for genetic variants selected through an extensive bibliographical review. We evaluated 
the associations found between our genetic data, the parameters and the resilience scores, 
searching for significant associations that could potentially explain the individual variability 
observed in resilience. 
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3 MATERIAL AND METHODS 
3.1 POPULATION IN STUDY 
 The population in study is part of the sample collected for the project “Impact Assessment 
on Employment Strategies for Health – biopsychosocial determinants in employment”, an 
observational study carried out with a sample of 400 Portuguese workers, to which a psychosocial 
questionnaire was applied and blood samples, anthropometric data and blood pressure 
measurements were collected. The psychosocial questionnaire was applied to the full sample, 
however blood samples were only collected for 261 individuals, and so these were the ones used 
for this association study (N = 261) [82,83].  
The psychosocial component included self-administered online questionnaire, that 
comprised the Connor-Davidson resilience scale (CD-RISC), a scale with sound psychometric 
properties that comprises 25 items, each rated on a 5-point scale, in which higher scores reflect 
greater resilience [85]. The items evaluated in this scale group into 5 factors: personal competence, 
high standards and tenacity, trust in one's instincts, tolerance of negative affect and strengthening 
effects of stress, positive acceptance of change and secure relationships with others, control. 
spiritual influences. In this case, resilience was also evaluated using the 10 item version of the CD-
RISC, obtained from the 25 item based on a psychometric analysis that allowed the identification of 
the 10 items that best captured the features of resilience with minimal redundancy [86].  
The questionnaire also included: 1) a short stress evaluation tool (ASSET), to assess the risk 
of workplace stress, that comprised two discrete subscales evaluating physical health and mental 
health. Lower scores indicated less physical and psychological symptomatology related to stress, 
respectively. 2) The Mental Health Index (MHI-5) scale, a discrete scale of 5 items used for the 
measurement of mental health status. 3) The Oslo Social Support scale, a discrete scale of 3 items 
that allows overall assessment of social support. 4) The Subjective Happiness Scale (SHS), a 
continuous scale comprised of 4 items, which evaluates one’s self-assessment of subjective 
happiness [87–90]. 
Socio-demographic, lifestyle and clinical data, including age, gender, marital status, level of 
education, practice of physical activity, suffering from anxiety and/or depression and taking sleeping 
pills, was also collected. 
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3.2 BIBLIOGRAPHIC REVISION 
For defining the genes and associated polymorphisms to be analysed, a bibliographic 
revision was carried out. Using keywords, such as “gene”, “resilience”, “polymorphism”, 
“depression”, “PTSD” in PubMed and google scholar, we were able to retrieve main papers covering 
these subjects. Several criteria were applied in order to select the more relevant papers, including 
date of publication (2005 – 2016), targeted population (human adults) and level of evidence 
(p<0.05). 
3.3 SAMPLE PREPARATION 
DNA was previously extracted from blood samples using a method based on the one 
previously described by Lahiri & Nuremberger, 1991[91]. All the DNAs were quantified using using 
a NanoDrop 1000 Spectrophotometer, version 3.7.1 (Thermo scientific, USA), at 260 nm and the 
associated software, and both the ratio of absorbance at 260 nm and 280 nm as well as the ratio of 
absorbance at 260 nm and 230 nm ratio were evaluated in order to determine the quality of the 
samples. Subsequently, 3 plates of 96 wells were prepared by diluting all the 261 genomic DNA 
samples to a final concentration of 50 ng/µL, taking into account the initial concentration of each 
sample. 
3.4 SNP GENOTYPING 
Genetic variants can take several forms, including single nucleotide polymorphisms (SNPs), 
defined as a variation on a single nucleotide that occurs at a specific position in the genome, or 
variable number of tandem repeats (VNTRs), consisting  of a DNA sequence motif that is repeated 
several times in the genome [11–13]. 
20 functional SNPs in selected genes were chosen to be genotyped based on the 
bibliographical review. A further 22 tag SNPs were used to analyse the full MAOA and BDNF genes, 
due to their influence in several neuronal pathways, mainly the hypothalamus-pituitary-adrenal 
(HPA) axis, and the noradrenergic and sympathetic nervous systems. The use of tag SNPs brings us 
the possibility to identify genetic variation and association to phenotypes without genotyping every 
SNP in a chromosomal region, for they are representative of a genomic region in which they are in 
high linkage disequilibrium with[53,92,93]. Tag SNPs were identified using the Haploview software, 
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version 4.2 (Broad Institute, USA), and the representative SNPs of each haplotype were chosen to 
be genotyped. 
3.4.1 Sequenom MassARRAY 
Sequenom’s MassARRAY genotyping platform is a multiplex assay, which allows the 
simultaneous amplification and detection of multiple markers per reaction. Multiplex assay can only 
occur if the molecular weight of the markers in the same PLEX are not equal. It consists of an initial 
locus-specific polymerase chain reaction (PCR), followed by an iPLEX assay, in which an 
oligonucleotide primer and the amplified target DNA are incubated with mass-modified 
dideoxynucleotide terminators, so that annealing occurs immediately upstream of the polymorphic 
site. By mass spectrometry (MALDI-TOF) it is possible to distinguish allele-specific primer extension 
products [94]. 
 3 plates of 96 wells were prepared by diluting all the genomic DNA samples to a final 
concentration of 15 ng/µL, using the initially prepared plates. Besides the population samples, 6 
HapMap individuals (NA07029, NA07357, NA10850, NA12044, NA12146, NA12057) were used as 
positive controls as well as 5 no template controls as negative controls. We genotyped 42 SNPs using 
Sequenom MassARRAY genotyping technology, with iPLEX chemistry and analysed the results with 
the MassARRAY TYPER software (Sequenom, USA), at Instituto Gulbenkian para a Ciência (IGC, 
Oeiras). 
3.4.2 Sanger Sequencing 
For the SNPs that were not called correctly through Sequenom MassARRAY, possibly due to 
less efficient extension reactions, we opted for making user calls. To be confident of the user calls 
we sequenced those polymorphisms for key individuals that would allow us to make those calls with 
greater confidence, by the Sanger method [95,96]. 
For this purpose, primers were designed using Primer3 software, version 0.4.0 (Whitehead 
Institute for Biomedical Research, USA) and polymerase chain reaction (PCR) amplification was 
carried out in an Applied Biosystems 2720 thermal cycler (Applied Biosystems, USA), in 25 µL 
reactions containing 10 pmol of each primer, 2 U of BIOTAQ™ DNA Polymerase (Bioline, UK) enzyme, 
25mM of MgCl2 (Bioloine, UK), 2 mM dNTPs, and 25 ng of genomic DNA. Thermal cycling conditions 
were as follows: an initial denaturation step at 94°C for 5 minutes, followed by 30 cycles of 94°C for 
30s, 56°C for 1min 30s and 72°C for 1min, and a last extension step of 72°C for 5min; for 3 SNPs 
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(rs7124442, rs112592173 and rs1870823) the thermal cycling conditions involved 35 cycles. PCR 
product analysis was carried out by electrophoresis in 1,5% SeaKem (Lonza, USA) agarose gel, using 
3,5 µL of 100 bp ladder and 10 µL of PCR product plus stain. The migration occurred for 45 min at 
90 V, after which we proceeded with the visualization of the genotype pattern using a system of 
image acquisition based on ultraviolet illumination. We followed with the purification of the PCR 
products, in 7 µL reactions containing 2 µL of illustra ExoProStar 1-Step (GE Healthcare, UK) and 5 
µL PCR product, and the conditions were as follows: 37°C for 15 min followed by 15 min at 80°. 
Lastly, the sequencing reaction occurred in 10 µL reactions containing 2 µL BigDye® Terminator v3.1 
Ready Reaction (Applied Biosystems, USA), 2 pmol of primer, forward or reverse according to the 
SNP, as well as 1 µL of purified PCR product. The sequencing conditions were as follows: an initial 
step of 1 min at 96°C, followed by 25 cycles of 96°C for 10 secs, 58°C for 5 secs and 55°C for 4 min. 
Capillary electrophoresis was performed by the Human Genetics Department of the National 
Institute of Health Dr. Ricardo Jorge and the chromatogram analysis was done with the Staden 
Package software, version 1.6.0 (Medical Research Council, UK). 
3.4.3 TaqMan® 5-nuclease assay 
The TaqMan® 5- nuclease assay is a PCR-based assay for genotyping SNPs, in which the region 
flanking the polymorphism is amplified in the presence of two allele-specific fluorescent probes, 
each labelled with a fluorescent reporter dye and attached with a fluorescence quencher. During 
PCR reaction, the 5’-nuclease activity of Taq DNA polymerase cleaves the hybridized probe that is 
perfectly matched, freeing the reporter dye from the quencher, and therefore generating 
fluorescence [97,98]. The TaqMan method is high throughput and highly accurate, precise and time-
efficient, and so was chosen for genotyping the one SNP (rs27072), that due to molecular weight 
incompatibility with the other SNPs, was not able to fit in the Sequenom MassARRAY assay. 
We carried out a TaqMan® 5-nuclease assay (C___2396868_10) in a 7900 HT fast Real-Time 
with fast 96-well block module (Applied Biosystems, USA) and the software associated. Reactions 
were performed in 96-well plates with 20 µL reaction volume containing 0.4 µL of 40x TaqMan® SNP 
Genotyping Assay (Applied Biosystems, USA), 2.5 µL of TaqMan® Genotyping Master Mix (Applied 
Biosystems, USA) and 50 ng genomic DNA. 2 Hapmap individuals (NA07029, NA07357, NA10850, 
NA12044, NA12146, NA12057) were used per 96-well plate as positive controls, as well as 2 no 
template controls.  
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3.5 VNTR GENOTYPING 
VNTR genotyping was carried out through PCR amplification, followed by electrophoresis in 
agarose gel, and the genotype of each individual was defined according to the size of the fragments 
obtained. 
3.5.1 SLC6A3 VNTR 
For the SLC6A3 40 bp VNTR, the PCR protocol was based on the previously defined by Drury 
et al., 2013, with some alterations. PCR optimization was carried out by firstly increasing the 
concentration of the BIOTAQ™ DNA Polymerase (Bioline, UK) enzyme to 2 U, followed by an increase 
in the annealing time, as well as the extension time, and lastly a decrease in cycles.  
In the end, PCR was performed in an Applied Biosystems 2720 thermal cycler (Applied 
Biosystems, USA), using the 5’ primer (forward) and 3’ primer (reverse) previously described in Drury 
et al. 2013. PCR was performed in 25 µL reactions with 10 pmol of each primer, 10 xNH4 (Bioline, 
UK), 25mM of MgCl2 (Bioloine, UK), 2 mM dNTPs, and 25 ng of genomic DNA. Thermal cycling 
conditions were as follows: an initial denaturation step at 95°C for 5 minutes, followed by 30 cycles 
of 94°C for 30s, 58°C for 1min 30s and 72°C for 1min, and a last extension step of 72°C for 10min. 
The analysis of the PCR products was carried out by electrophoresis in 3% NuSieve (Lonza, USA) 
agarose gel, using 3 µL of 100 bp ladder and 9 µL of PCR product plus stain. The migration occurred 
for approximately 3 hours at 60 V, after which we proceeded with the visualization of the genotype 
pattern using a system of image acquisition based on ultraviolet illumination. 
3.5.2 DRD4 VNTR 
For the DRD4 48 bp VNTR, the amplification primers were designed with the Primer3 
software, version 0.4.0 (Whitehead Institute for Biomedical Research, USA), and were as follows: 
forward 5’-CCGTGTGCTCCTTCTTCCTA-3’ and reverse 5’-GTCTGCGGTGGAGTCTGG-3’. Using as a start 
the procedure described by Hwang et al., 2012, optimization was carried out by firstly increasing 
the annealing time, followed by an increase in the extension time, and finally a decrease in cycles 
[99]. As such, PCR was performed in an Applied Biosystems 2720 thermal cycler (Applied Biosystems, 
USA) in 25 µL reactions, as described above. Thermal cycling conditions were as follows: an initial 
denaturation step at 95°C for 5 minutes, followed by 30 cycles of 95°C for 20s, 54°C for 1min 30s 
and 72°C for 45s, and a last extension step of 72°C for 10min. The analysis of the PCR products was 
carried out by electrophoresis in 4% NuSieve (Lonza, USA) agarose gel, as described above. 
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3.5.3 MAOA VNTR 
For the MAOA 30 bp VNTR, PCR amplification occurred in an Applied Biosystems 2720 
thermal cycler (Applied Biosystems, USA) in 25 µL reactions as described above, with 10 pmol of 
each primer, previously described in Caspi et al., 2002. PCR optimization was carried out by firstly 
testing the thermal cycling conditions defined by Caspi et al., 2002, followed by trials of increased 
annealing time, decreased extension time, and fewer cycles. Lastly, we also tested the thermal 
cycling conditions previously described by Nikulina, Widom and Brzustowicz, 2012 [50,73]. The 
analysis of the PCR products was carried out by electrophoresis in 4% NuSieve (Lonza, USA) agarose 
gel, as described above. 
3.5.4 5HTTLPR VNTR 
Lastly, for the 5HTTLPR 23 bp VNTR, amplification primers were designed using the Primer3 
software version 0.4.0 (Whitehead Institute for Biomedical Research, USA), and were as follows: 
forward 5’-GCCAGCACCTAACCCTAAT-3’ and reverse 5’-GTGCCACCTAGACGCCAG-3’. PCR was carried 
out in 25 µL reactions as described above, in an Applied Biosystems 2720 thermal cycler (Applied 
Biosystems, USA). PCR optimization was carried out by firstly testing the conditions previously 
described by Cook Jr et al., 1997, followed by alterations regarding the annealing time, extension 
time and number of cycles, as well as addition of enhancement agents, specifically DMSO (1%) 
(Invitrogen, USA) and gelatin from porcine skin (0.025%) (Sigma-Aldrich, USA) [100].The analysis of 
the PCR products was carried out by electrophoresis in 4% NuSieve (Lonza, USA) agarose gel, as 
described above. 
3.6 QUALITY CONTROL ANALYSIS 
Extensive quality control for all assays was performed by applying several criteria: Call rates 
of <90%, no correspondence with the positive controls, contamination of negative controls, 
meaning those whose spectrum peak is equal to the expected for the DNA samples, and deviation 
from Hardy-Weinberg equilibrium (HWE), calculated with Arlequin software, version 3.5.2.2 
(University of Berne, Switzerland) led to polymorphism exclusion from the analysis. Regarding the 
gene located in the X chromosome, the same criteria was applied but only to the females, as males 
only have one copy of this gene and therefore HWE cannot be calculated for these cases. Individuals 
with less than 90% call rates were also excluded from the analysis. 
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3.7  STATISTICAL ANALYSIS 
All statistical inferences were done using SPSS, version 23 (IBM, USA). To test the normality 
of our CD-RISC data we used the Shapiro-Wilk test, since considering our sample size this is the most 
potent test [101]. As there were two different versions of the CD-RISC scale, the 25 item and 10 
item, we evaluated the correlation between the two scales by applying the Pearson product-
moment correlation coefficient, considering a strong relationship for a coefficient higher than 0.8. 
 Haplotypes were inferred with the Arlequin software, version 3.5.2.2 (University of Berne, 
Switzerland), for the BDNF and MAOA tag SNPs, using an expectation-maximization (EM) algorithm 
to make maximum-likelihood estimates of molecular haplotype frequencies [102]. 
Univariate analysis was used to assess associations between the resilience scores and socio-
demographic, lifestyle and clinical parameters, such as level of education, marital status, blood 
pressure, practicing physical activity, suffering from depression, suffering from anxiety and taking 
sleeping pills, and also the scores obtained for selected psychometric scales, namely the MHI-5, SHS, 
Oslo and the physical and mental health subscale of the ASSET. We considered good to fit the 
multivariate analysis the parameters that had a significance level <0.15 for the one-way analysis of 
variance (ANOVA) and were included as co-variants in the multivariate regression analysis. The 
association between the score values of the CD-RISC scale and the molecular markers at each gene 
was evaluated by linear regression analysis, considering both genotype and haplotypes for the BDNF 
and MAOA genes, which were all dummy coded, and alleles, by analysing the occurrence of 1 or 2 
copies of each allele. For the markers located in the X chromosome, the analysis was performed for 
both genders separately. 
Multivariate regression analysis was conducted through forward selection, in which we 
started by selecting the most significant variables in the univariate analysis, and continued adding 
other variables until there were no changes to the model [103]. It was defined that age and gender 
would enter the models, even if not individually associated, as these parameters are important for 
population context. The effect of several markers from different genes and different chromosomes 
was tested and the objective was to understand the impact of each marker on resilience, so a 
different model for each significant marker will be obtained, instead of a single model that would 
explain overall resilience scores, and as such no correction for multiple testing was applied [104].  
Molecular Genetics of Resilience 
19 
 
4 RESULTS 
4.1 BIBLIOGRAPHICAL REVIEW 
An extensive bibliographical review allowed us to pinpoint the most relevant genes and 
polymorphisms associated with resilience, stress and psychiatric disorders, like depression and post-
traumatic stress disorder (PTSD), by using the following criteria: date of publication (2005 – 2016), 
targeted population (human adults) and level of evidence (p < 0.05). In total, we selected 10 
different genes and 15 associated polymorphisms linked to the stress response mechanism, 
especially the hypothalamic-pituitary-adrenal (HPA) axis, the noradrenergic and sympathetic 
nervous systems, as well as the dopaminergic and serotonergic systems (Table 1). 
Table 1 - Selected genes and polymorphisms 
Gene Polimorphism Functional Annotation References Genotyping Technique 
COMT rs4680 Missense 
[45,51,55,57] 
Sequenom MassARRAY 
 rs165599 3' - UTR Sequenom MassARRAY 
 rs2097603 Intronic Sequenom MassARRAY 
BDNF rs6265 Missense [35,37,105] Sequenom MassARRAY 
NPY rs16142 5'-UTR 
[106–108] 
Sequenom MassARRAY 
 rs2023890 downstream Sequenom MassARRAY 
SLC6A4 rs25533 5'-UTR 
[7,32,109–113] 
Sequenom MassARRAY 
 rs1042173 3'-UTR Sequenom MassARRAY 
 VNTR Intronic PCR and electrophoresis 
OXTR rs53576 Intronic 
[27,39,41,114] 
Sequenom MassARRAY 
 rs2254298 Intronic Sequenom MassARRAY 
CRHR1 rs242924 Intronic 
[31–34,115] 
Sequenom MassARRAY 
 rs4792887 Sinonymous Sequenom MassARRAY 
 rs7209436 Intronic Sequenom MassARRAY 
 rs110402 Intronic Sequenom MassARRAY 
MAOA VNTR Upstream [50,116–118] PCR and electrophoresis 
FKBP5 rs1360780 Intronic 
[28,29,33,119–122] 
Sequenom MassARRAY 
 rs3800373 3'-UTR Sequenom MassARRAY 
 rs4713916 Intronic Sequenom MassARRAY 
 rs9296158 Intronic Sequenom MassARRAY 
 rs9470080 Intronic Sequenom MassARRAY 
DRD4 rs1870723 Intronic 
[123–126] 
Sequenom MassARRAY 
 VNTR Exonic PCR and electrophoresis 
SLC6A3 
 
rs27072 3'-UTR 
[68,75,76,127] 
TaqMan® 5- nuclease assay 
VNTR 3'-UTR PCR and electrophoresis 
Due to the big influence of the MAOA and BDNF genes in the neurologic pathways, mainly 
the HPA axis, as well as the noradrenergic and sympathetic nervous systems, we used tag single 
nucleotide polymorphisms (SNPs) in an attempt to scan the full genetic variations for association 
with resilience [53,92,93]. Regarding the BDNF gene, till November 2015 there had been described 
424 SNPs in total, which could be tagged with 12 tag SNPs, whilst the MAOA gene comprised 3020 
SNPs in total that could be tagged with 11 different tag SNPs (Table 2). 
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Table 2 - Selected tag SNPs for the MAOA and BDNF genes 
Gene Size # total 
SNPs 
# tag 
SNPs 
Choosen 
polymorphisms 
Functional 
annotation 
Genotyping Technique 
BDNF 67164 bp 424 12 rs6265 
rs7124442 
rs11030099 
rs11030101 
rs11030102 
rs4923464 
rs189740576 
rs77135086 
rs75298795 
rs76324918 
rs66866077 
rs2030324 
Missense 
3’-UTR 
3’-UTR 
5’-UTR 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Sinonymous 
Nonsense 
Intronic 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
MAOA 91918 bp 3020 11 rs3788862 
rs73211189 
rs142677545 
rs147023114 
rs5905809 
rs112592173 
rs201583370 
rs909525 
rs5905823 
rs142369182 
rs140878834 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Intronic 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
Sequenom MassARRAY 
4.2 QUALITY CONTROL ANALYSIS 
Altogether, we genotyped a total of 42 SNPs by Sequenom MassARRAY (Fig. 4), 1 SNP by 
TaqMan® 5- nuclease assay (Fig. 4), and 2 variable number tandem repeats (VNTRs) by polymerase 
chain reaction (PCR) and electrophoresis. 
 
 
 
 
 
 
Fig. 4 - Examples of genotyping results obtained with (A) Sequenom MassARRAY (B) TaqMan 5-nuclease assay. (A) – 
Genotypes obtained for the rs9470080 polymorphism using Sequenom MassARRAY; Orange – TT genotype; green – CT 
genotype; blue – CC genotype. (B) – Genotypes obtained for the rs27072 polymorphism using TaqMan 5’-nuclease assay; 
blue – TT genotype; green – CT genotype; red – CC genotype. 
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We observed that 37 SNPs passed all the quality control criteria. We verified 6 SNPs that did 
not pass quality control: 1 that showed deviation from Hardy-Weinberg Equilibrium (HWE), 3 whose 
HapMap individuals did not correspond with the expected, and 2 others that not only showed 
deviation from HWE, but also whose HapMap individuals did not correspond with the expected. 
Furtermore, we also observed 3 monomorphic SNPs, but as they are not informative for association 
studies, we did not proceed with the analysis of these polymorphisms (Table S1). Of all 261 
individuals, 2 had call rates <90% (AIS271 and AIS316), 2 had incomplete questionnaires (AIS40 and 
AIS370), and a final one (AIS334), had genotype calls for some molecular markers that were 
inconsistent with the gender of the individual, and so they were excluded from the analysis. 
In some cases, the MassARRAY TYPER software (Sequenom, USA) did not classify the signal 
with confidence, and so we classified these genotypes through manual inspection. These user calls 
were validated by Sanger sequencing in a proportion of key individuals, so that we could have 
confidence in the genotype calls. For some of these SNPs (rs7124442, rs1870723 and rs11259173), 
we were not able to confidently assign genotypes. These SNPs presented deviation from HWE, 
indicating a technical artifact, thus could not be genotyped. 
Variable number tandem repeat (VNTR) genotyping was carried out by polymerase chain 
reaction (PCR) amplification, followed by electrophoresis in agarose gel, and the genotype of each 
individual was defined according to the size of the fragments obtained. Regarding the 40 base pair 
(bp) SLC6A3 VNTR, we found the 10 repetition allele (10R) the most frequent, followed by the 9 
repetition allele (9R). We also found that the most observed genotype was the homozygous 
10R/10R, followed by the heterozygous 10R/9R (Fig. 5). 
 
 
 
 
Fig. 5 - Genotype pattern for the 40 bp SLC6A3 VNTR. Lanes 4, 6, 7, 8, 10, 11, 14 and 16 are homozygous for the 10 
repetition allele (480 bp), lane 5 is homozygous for the 9 repetition allele (440 bp) and lanes 2, 3, 9, 12, 13, 15 and 17 are 
heterozygous for the 9 and 10 repetition allele; first and last lane labelled 100 bp as the molecular weight marker, all other 
lanes are identified with the ID of the individual. 
Concerning the 48 bp DRD4 VNTR, we found this population to be monomorphic, with all 
individuals presenting themselves as homozygous for the 4 repetition allele (540bp) (Fig. S1). The 
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30 bp MAOA VNTR and the 23 bp 5HTTLPR VNTR presented artifacts caused by the PCR reaction, 
that despite all efforts of optimization described in methods, were not well resolved. The genotyping 
of these VNTRs was not carried out (Fig. S2). The same quality control criteria were applied for the 
VNTRs genotyped, except the HapMap correspondence, as we did not have HapMaps with known 
genotype calls for these polymorphisms. They both passed all quality control applied. As the 40 bp 
DRD4 VNTR was monomorphic, and so not informative for an association study, we did not proceed 
with the analysis of this polymorphism.  
4.3 STATISTICAL ANALYSIS 
We tested the normal distribution of the CD-RISC data using the Shapiro-Wilk test,  since 
considering our sample size this is the most potent test [101], and established the normality of the 
distribution. The Pearson correlation coefficient revealed a positive correlation of over 0.8 between 
the 10 item CD-RISC and the 25 item CD-RISC, and so we opted to only use the 10 item scale, as it is 
the least redundant. 
We detected associations between resilience and several parameters, namely suffering 
from depression, suffering from anxiety and the level of education.  The analysis revealed that 
individuals who suffered from anxiety, depression or were taking sleeping pills had lower resilience 
score, whilst individuals who had higher levels of education, namely post-graduate studies and 
professional courses, had higher resilience scores. We found no association of resilience with gender 
or age, but as these are important for population context, they were also used for the multivariate 
analysis. We found no association between marital status, practising physical activity, taking 
sleeping pills or blood pressure (Table 3).  
There were also significant associations between the scores obtained for the Subjective 
Happiness Scale (SHS), the Mental Health Index (MHI-5), the Oslo Social Support scale and the 
physical and mental health scales from ASSET, and the resilience scores. Individuals who scored 
higher in the SHS and MHI-5, indicating individuals who considered themselves happy and had a 
better mental health status, as well as individuals with lower ASSET physical and mental health 
scores, meaning those who present less symptomatology, both physical and psychological, 
associated to stress, revealed higher resilience scores. On the other hand, we also observed that 
individuals that scored lower in the Oslo social support scale, indicating lower social support, had 
higher resilience scores (Table 3). 
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Table 3 - Demographic measures and univariate analysis results for the parameters in study 
Parameters Population in study β 95% CI ANOVA p-value 
Age, mean ± SD (years) 42,28 ± 0.528 0.085 -0.019 – 0.100 0.177 
Gender  -0.026 -1.221 – 0.798 0.680 
Gender, male n/N (%) 118/256 (46) 
  
 
Gender, female n/N (%) 138/256 (54)  
Marital Status, n/N (%)    0.285 
single 53/256 (21) -0.112 -2.386 – 0.141  
Married/cohabitation 169/256 (66)    
Divorced/seperated 30/256 (12) 0.001 -1.581 – 1.599  
Widow(er) 4/256 (2) 0.042 -2.668 – 5.452  
Level of education, n/N (%)    0.024 
Not graduate 68/256 (27) 0.073 -0.542 – 1.882  
Graduate 116/256 (45)    
Post-graduate 68/256 (27) 0.168 0.341 – 2.765  
Others 4/256 (2) 0.130 0.223 – 8.294  
Physical Activity, n/N (%)    0.481 
Always 25/256 (10) 0.060 -1.084 – 2.738  
Frequently 41/256 (16) 0.139 -0.082 – 3.168  
When possible 61/256 (24)    
On occasion 43/256 (17) 0.030 -1.281 – 1.924  
Rarely 51/256 (20) 0.029 -1.230 – 1.823  
Never 35/256 (14) -0.004 -1.748 – 1.665  
Suffer from depression, n/N (%)    0.007 
No 177/256 (69)    
Yes 55/256 (21) -0.176 -2.966 - -0.523  
Does not know/refused to answer 24/256 (9) -0.120 -3.402 – 0.041  
Suffer from anxiety, n/N (%)    0.000 
No 210/256 (82)    
Yes 21/256 (8) -0.273 -5.802 - -2.302  
Does not know/refused to answer 25/256 (10) -0.195 -4.301 - -1.065  
Take sleeping pills, n/N (%)    0.096 
Yes 33/256 (13) -0.104 -2.760 – 0.228  
No 223/256 (87)    
Blood pressure, n/N (%)    0.890 
Normal 135/256 (53)    
Prehypertension/hypertension/crisis 121/256 (47) -0.009 -1.079 – 0.937  
Oslo scores, mean ± SD 7.50 ± 1.420 -0.102 -0.645 – 0.062 0.105 
SHS scores, mean ± SD 5.30 ± 1.07 0.367 0.960 – 1.835 0.000 
MHI-5 scores, n/N (%)    0.000 
<=52 28/256 (11) 0.259 1.817 – 4.933  
>52 228/256 (89)    
Physical health scores, mean ± SD 12.25 ± 4.073 -0.230 -0.351 - -0.110 0.000 
Mental health scores, mean ± SD 41 ± 6.938 -0.464 -0.337 - -0.209 0.000 
Linear regression analysis of each marker with the resilience scores revealed one single SNP 
in the MAOA gene (rs142369182) significantly associated (p<0.05) with resilience. However, 
haplotype analysis did not support these results (Table S2). 
To evaluate the influence of genetic polymorphisms on resilience scores, after adjusting for 
potential confounding variables, comprising age, gender, SHS scores and mental health scores from 
ASSET, we used a multivariate regression analysis. This multivariable analysis revealed a significant 
association (p-value<0.05) between resilience scores and the “AA” genotype for the rs53576 
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polymorphism from the OXTR gene (p-value = 0.015; β [95% CI] = -0.130 [-3.447 - -0.271]), after 
adjusting for confounding variables, with this model explaining almost 27% of the variability on 
resilience scores observed in our population (R2=0.269). This model indicates that individuals who 
possess the “AA” genotype for the OXTR polymorphism have lower resilience scores. At the allelic 
level, the multivariable analysis revealed an association between the “G” allele of this marker (p-
value = 0.017; β [95% CI] = 0.137 [0.352 - 3.560]) and higher resilience scores, indicating that 
individuals with one or two copies of the “G” allele are more resilient than individuals with two 
copies of the “A” allele (Table 4). 
We also identified a significant association (p-value<0.05) between resilience scores and the 
“9R/10R” genotype for the SLC6A3 40 bp VNTR (p-value = 0.014; β [95% CI] = -0.138 [-2.072 - -
0.181]), after adjusting for confounding variables, with this model explaining almost 29% of the 
variability of resilience scores observed in the population in study (R2=0.289), and revealing that 
individuals who possess both the 9 repetition allele and 10 repetition allele for the SLC6A3 40 bp 
VNTR have lower resilience scores. At the allelic level, we identified a significant association (p-
value<0.05) between the “9R” allele of this marker (p-value = 0.020; β [95% CI] = -0.140 [-2.072 -  -
0.181]) and lower resilience scores (Table 4). 
Table 4 - Multivariate genotypic and allelica analysis results for the polymorphisms associated with CD-RISC 10 scores 
Variables β 95% CI p-value Variables β 95% CI p-value 
Age 0.088 -0.010 - 0.095 0.115 Age 0.078 -0.015 - 0.090 0.162 
Gender 0.087 -0.195 - 1.611 0.124 Gender 0.093 -0.144 - 1.647 0.100 
SHS scores 0.177 0.203 - 1.147 0.005 SHS scores 0.178 0.192 - 1.145 0.006 
Mental 
health 
scores 
-0.389 -0.303 -  -0.155 0.000 Mental health 
scores 
-0.401 -0.305 -  -0.159 0.000 
rs53576 
(OXTR) 
   SLC6A3 40 bp 
VNTR 
   
AA -0.130 -3.447 -  -0.271 0.015 10R/10R    
AG 0.012 -0.827 – 1.020 0.837 10R/9R -0.138 -2.072 -  -0.181 0.014 
GG    9R/9R 0.023 -1.606 – 1.240 0.800 
A 0.012 -0.827 – 1.020 0.837 10R/11R 0.037 -5.340 – 2.648 0.507 
G 0.137 0.352 – 3.560 0.017 10R/3R 0.056 -3.335 – 10.477 0.309 
R2 0.269 10R/8R .0023 -2.787 – 4.246 0.683 
  10R 
9R 
11R 
8R 
3R 
-0.075 
-0.140 
-0.037 
0.023 
0.056 
-2.387 – 0.500 
-2.072 - -1.181 
-5.340 – 2.648 
-2.787 – 4.246 
-3.335 – 10.477 
0.199 
0.020 
0.507 
0.683 
0.309 
  R2 0.289 
 No other molecular marker revealed a significant association with the resilience scores during 
the multivariable analysis, either at the genotypic level nor at the allelic level (Table S3).  
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5 DISCUSSION 
We successfully genotyped 37 single nucleotide polymorphisms (SNPs) and 2 variable number 
tandem repeats (VNTRs), mapping 10 different genes. Besides these, we found 3 SNPs to be 
monomorphic, which goes against the expected, as it did not correspond to the minor allele 
frequency (MAF) described for these SNPs in the European population. We also had to exclude 6 
other SNPs for whom the genotype calls of HapMap individuals did not correspond with the 
expected and/or presented deviation from Hardy-Weinberg Equilibrium (HWE). 
In Europe and Middle East populations, the most common allele for the 48 bp DRD4 VNTR 
is the 4 repetition allele (4R) (~70%), followed by the 7 repetition allele (7R) (~20%), even though in 
some European populations, namely the Sardinians, these distributions vary, showing no 
representation of the 7R [128]. Regarding the Portuguese population, studies concerning this 
polymorphism have mainly included schizophrenic trios. In one of these studies, healthy controls 
with no history of psychiatric disorders were used, demonstrating the presence of the 7R allele in 
the healthy Portuguese population, and therefore we would expect to see variability in our 
population in study as well [129,130]. As we did not, this polymorphism was excluded from the 
analysis. 
Concerning the 30 bp MAOA VNTR and the 23 bp 5HTTLPR VNTR, we were not able to 
correctly genotype what we can only assume to be the heterozygous individuals, who presented an 
artifact caused by the polymerase chain reaction (PCR). The artifact present in both VNTRs appeared 
as a fragment of slower migration than the other two expected fragments, which leads us to believe 
that it is being caused by the reannealing of complementary fragments that have sequence 
differences, since the repeats are so similar [131–133]. Despite all efforts of optimization, including 
many alterations in thermocycling conditions, the use of enhancement agents and other previously 
described protocols, the full genotyping of these VNTRs was not carried out at this time, since the 
presence of this artifact did not give us the confidence to genotype with certainty these individuals. 
Other methods, such as fragment analysis, should be tested. 
The absence of association between resilience scores and age or gender in the univariate 
analysis is indicative that resilience, as an intrinsic characteristic, does not alter with age nor does it 
vary between genders. The lack of association between blood pressure and resilience is revealing 
that the cardiovascular problems usually associated to the hyper-response of the noradrenergic and 
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sympathetic nervous system (SNS), are not indicative of a person’s resilience, and there must be 
other factors influncing these symptoms [46,48,49].  
As depression and anxiety are psychiatric disorders related to the imbalance of the stress 
response systems, the association indicating that individuals that suffer from such disorders are less 
resilient, reveals the influence of the stress response mechanism on the capability to adaptively 
overcome adversity [134,135]. In line with this goes the trend for association here found between 
the consumption of sleeping pills and resilience, indicating that individuals who take sleeping pills 
are less resilient, as sleep disturbances are considered risk factors for development of depression 
and anxiety [136]. 
 On another note, assuming that individuals who proceed with their studies have a different 
life experience than the ones who do not, and possibly encounter different stressful situations, the 
association observed between individuals with postgraduate studies as well as individuals with 
professional courses and a greater capacity to overcome stress and adversity, can be seen as the 
impact of personal experience on the creation of personal resources that allow a more adequate 
response to stressful stimulus, and ultimately on resilience. 
 The univariate regression analysis revealed an association between the resilience scores and 
one single SNP in the MAOA gene (rs142369182), but as we did not found any association between 
the haplotypes involving this polymorphism and resilience, it is possibly a false positive. 
The association between the Oslo Social Support scale and resilience revealing that 
individuals with less social support are more resilient goes against previous studies that identified 
low social support to be associated with physiological and neuroendocrine indices of heightened 
stress reactivity. This may be due to the lack of representability of the population in study for this 
scale, as the mean score is 7.50 ± 1.420 and the range is 4 – 12, with a reduced number of individuals 
presenting “strong social support” [88,139]. 
As seen by the results of the multivariable analysis, positive emotions and moods moderate 
resilience in a way that is demonstrative of how a positive mind-set helps build an individual’s 
personal resources so that he/she has effective coping mechanisms allowing him to adaptively 
overcome stress and adversity. This result is concordant with the broaden-and-build theory of 
positive emotions that states that experiences of positive emotions broaden people’s momentary 
thought-action repertoires, which in turn serves to build their enduring personal resources [140–
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142]. Furthermore, this finding also falls in line with previous studies that have indicated that certain 
mind sets can modulate glucocorticoid reactivity, the main hormone of the HPA axis, and in that 
way possibly impact the stress response mechanism [143] . 
The association identified between the absence of stress related symptomatology and 
higher resilience shows how a flexible and suitable biological stress response is necessary in order 
to maintain normal physical and psychological functioning in context of adversity, which goes 
accordingly with previous studies that indicate that a suitable stress response is necessary for 
sustained health in the face of adversity [4,5]. It is noteworthy that the association between less 
symptomatology related to stress and higher resilience highlights the importance of the biological 
component of this trait, mainly the stress response mechanism that is composed by several 
neurological and neurochemical and is, to a certain extent, modulated by a genetic component.  
The polymorphism rs53576 from the OXRT gene is an intronic variant of functionality 
unknown that causes the alteration of a guanine (“G”) to an adenine (“A”) and has been previously 
linked to not only alterations in social behaviour, with several studies indicating that carriers of the 
“G” allele exhibit more empathy, report being less lonely and tend to be more optimistic when 
compared with “A” allele carriers, but also with alterations in brain structures that compose and 
modulate the HPA axis, namely the hypothalamus and the amygdala [38,41,144]. The association 
seen in the multivariable analysis between carriers of the “G” allele and greater resilience, when 
compared with individuals homozygous for the “A” allele, goes in line with these studies, indicating 
that this variant impacts the receptor’s function, and thus the oxytocin pathway and regulation of 
the HPA axis, in such a way that it can modulate positive emotions, and consequently resilience. 
 The 40 bp VNTR localized in the 3’ untranslated region of the SLC6A3 gene is a functional 
polymorphism that affects protein expression, with most studies stating that carriers of the 9 
repetition (9R) allele have a less active dopamine transporter, when compared with the 10 
repetition (10R) allele carriers. As such, this 9R allele has been associated with increased risk of 
lifetime post-traumatic stress disorder (PTSD), substance abuse and cigarette smoking, as well as 
aggressive and antisocial behaviour [145,146]. The significant association found in the multivariate 
analysis between carriers of the “9R” allele and lower resilience goes in line with the previous 
studies, and suggests that this allele is responsible for the decrease in the transporter’s expression, 
thus affecting the stress response mechanism. This effect on the stress response mechanism can 
possibly be related with amygdala reactivity, as proposed by Bergman et al., 2014, as dopaminergic 
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neurons project to this region, leading to alterations in emotional reactions and memory processing, 
and causing variability in emotional resilience. However, it should be noted that the genotypic 
analysis only showed a significant association with the “9R/10R” genotype and not with the “9R/9R”, 
as was also expected considering the allelic analysis. This was due to the fact that this genotype is 
poorly represented in our population (12%), when compared to the heterozygous genotype. 
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6 CONCLUSIONS AND FUTURE PERSPECTIVES 
This study provides evidence of the influence of the SLC6A3 and OXTR genes in the capacity to 
adaptively overcome stress, as we saw that genetic alterations in these genes modulate variability 
in resilience, possibly by affecting protein expression and causing alterations on the stress response 
mechanisms. 
We also found evidence of the importance of a positive mind-set as well as a suitable stress 
response mechanism in modulating the capacity to overcome adversity, as we verified an 
association between positive emotions and moods and the absence of symptomatology associated 
to stress with higher resilience.  
The results here described are consistent with previous literature, which reinforces the role of 
these genes in resilience and indicates that these must not be false positives. 
This study presents some limitations, starting with the size of our sample that was limited and 
sometimes not representative of certain genotypes and so did not confer sufficient statistical power 
to detect certain effects, which might lead to false negatives. We also opted for not applying a 
correction for multiple testing as we wished to analyse the impact of different molecular markers 
separately, and did not intend to find a single model that would explain overall resilience scores, so 
results should be seen as exploratory. It should be kept in mind, that resilience is an extremely 
complex trait that involves several neurological and neurochemical pathways, and so is likely 
influenced by multiple genes and their interactions, as well as environmental factors and their 
interactions, and it was not possible to evaluate all possible genes involved in those pathways or all 
environmental factors that could potentially influence resilience, and so the results here found 
might not uphold in a wider range association study. 
As to future perspectives for this work, we propose that other methods should be tested, in 
order to correctly genotype the variants not successfully genotyped in this study. Replication of 
these associations in larger population samples, together with approaches that test gene-gene 
interaction, will contribute for the validation of these results. 
In conclusion, this study points to the influence of genetic factors as well as environmental 
factors on resilience, and the importance of studying these two components to truly understand 
this complex trait.  
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8 SUPPLEMENTARY MATERIAL 
Table S1 -  Quality control results for all polymorphisms genotyped 
Gene Polymorphism MAF Call Rates (%) Contaminated 
Waters 
HapMap 
correspondence 
HWE 
´FKBP5 rs1360780 
rs3800373 
rs4713916 
rs9296158 
rs9470080 
31% (T) 
29% (C) 
32% (A) 
30% (A) 
33% (T) 
99% 
100% 
100% 
98% 
100% 
0% 
0% 
0% 
0% 
0% 
100% 
100% 
100% 
100% 
100% 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
CRHR1 rs242924 
rs4792887 
rs7209436 
rs110402 
45% (T) 
8% (T) 
43% (T) 
45% (A) 
95% 
99% 
99% 
99% 
0% 
0% 
0% 
0% 
100% 
100% 
100% 
100% 
equilibirum 
equilibrium 
equilibrium 
equilibrium 
OXTR rs53576 
rs2254298 
35% (A) 
11% (A) 
100% 
99% 
0% 
0% 
100% 
100% 
equilibrium 
equilibrium 
BDNF rs6265 
rs2030324 
rs4923464 
rs7124442 
rs11030099 
rs11030101 
rs11030102 
rs66866077 
rs75298795 
rs76324918 
rs77135086 
rs189740576 
20% (T) 
48% (G) 
22% (T) 
29% (C 
22% (A) 
46% (T) 
23% (G) 
4% (T) 
12% (T) 
6% (C) 
8% (T) 
11% (G) 
99% 
99% 
100% 
99% 
95% 
99% 
99% 
100% 
99% 
99% 
100% 
100% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
100% 
100% 
100% 
33% 
0% 
100% 
100% 
100% 
100% 
100% 
100% 
100% 
equilibrium 
equilibrium 
- (monomorphic) 
deviation (*) 
- (monomorphic) 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
- (monomorphic) 
NPY rs16142 
rs2023890 
26% (G) 
23% (G) 
99% 
99% 
0% 
0% 
100% 
100% 
equilibrium 
equilibrium 
COMT rs4680 
rs165599 
rs2097603 
50% (A) 
31% (G) 
41% (G) 
99% 
100% 
98% 
0% 
0% 
0% 
100% 
100% 
100% 
equilibrium 
equilibrium 
equilibrium 
MAOA rs909525 
rs3788862 
rs5905809 
rs5905823 
rs73211189 
rs112592173 
rs140878834 
rs142369182 
rs142677545 
rs147023114 
rs201583370 
34% (C) 
29% (A) 
27% (G) 
25% (G) 
20% (T) 
8% (T) 
23% (G) 
6% (T) 
5% (A) 
8% (T) 
6% (T) 
100% 
100% 
99% 
100% 
99% 
99% 
100% 
90% 
99% 
99% 
100% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
0% 
100% 
100% 
100% 
100% 
100% 
0% 
50% 
100% 
100% 
100% 
100% 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
deviation (*) 
- (monomorphic) 
equilibrium 
equilibrium 
equilibrium 
equilibrium 
SLC6A3 rs27072 
VNTR 
21% (T) 90% 
98% 
0% 
0% 
67% 
- 
equilibrium 
equilibrium 
SLC6A4 rs25533 
rs1042173 
6% (G) 
44% (C) 
100% 
99% 
0% 
0% 
100% 
100% 
- (monomorphic) 
equilibrium 
DRD4 rs1870723 
VNTR 
24% (A) 99% 
91% 
0% 
0% 
100% 
- 
deviation (*) 
- (monomorphic) 
(*) – p<0.05  
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Fig. S1 - Genotype pattern for the 48 bp DRD4 VNTR. All individuals present the 4 repetition allele (540bp); first and last 
lane labelled 100 bp as the molecular weight marker, all other lanes are identified with the ID of the individual in question. 
Fig. S2 - Genotype pattern for (A) – 23 bp 5HTTLPR VNTR and (B) – 30 bp MAOA VNTR. (A) – lane 4, 6 and 9 are presumably 
homozygous for the 16 repetition allele (419 bp), lane 2, 3, 7 and 8 are the presumed heterozygous for the 16 and 14 
repetition allele (419 and 375 bp respectively) where the artifact is noticeable; (B) – lane 3 is presumably homozygous for 
the 3 repetition allele (350 bp), lane 4, 6, 7 and 9 are presumably homozygous for the 4 repetition allele (380 bp), lane 2 
and 8 are the presumed heterozygous for the 3 and 4 repetition allele (350 bp and 380 bp respectively) where the artifact 
is noticeable; first and last lane labelled 100 bp as the molecular weight marker, all other lanes are identified with the ID 
of the individual in question. 
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Gene Genetic markersPopulation in study, n/N (%) β 95% CI ANOVA p-value Gene Genetic markers Allelic Frequency β 95% CI ANOVA p-value
FKBP5 rs1360780 0.921 FKBP5 rs1360780 0.921
CC 119/256 (46) C 68% 0.023 -1.412 - 2.006
CT 109/256 (43) 0.021 -0.896 - 1.243 T 32% 0.021 -0.896 - 1.243
TT 28/256 (11) -0.009 -1.818 - 1.571 rs3800373 0.541
rs3800373 0.541 A 71% 0.071 -0.831 - 2.822
AA 130/256 (51) -0.047 -2.449 - 1.128 C 29% 0.041 -0.730 - 1.400
CA 102/256 (40) 0.040 -0.730 - 1.400 rs4713916 0.537
CC 24/256 (9) A 27% -0.051 -1.1487 - 0.646
rs4713916 0.537 G 73% -0.067 -2.931 - 0-944
AA 21/256 (8) 0.039 -1.313 - 2.458 rs9296158 0.810
GA 97/256 (38) -0.050 -1.1487 - 0.646 A 31% 0.030 -0.833 - 1.322
GG 138/256 (54) G 69% 0.039 -1.240 - 2.304
rs9296158 0.810 rs9470080 0.969
AA 26/253 (10) -0.021 -2.038 - 1.463 C 67% 0.008 -1.583 - 1.783
GA 106/253 (42) 0.029 -0.833 - 1.322 T 33% 0.016 -0.931 - 1.206
GG 121/253 (48) CRHR1 rs4792887 0.640
rs9470080 0.969 C 91% 0.055 -3.279 - 8.370
CC 116/256 (45) T 9% -0.014 -1.485 - 1.186
CT 111/256 (43) 0.016 -0.937 - 1.206 rs110402 0.453
TT 29/256 (11) 0.003 -1.641 - 1.710 C 63% 0.008 -1.433 - 1.631
CRHR1 rs4792887 0.640 T 37% 0.081 -0.410 - 1.765
CC 210/256 (82) rs7209436 0.408
CT 44/256 (17) -0.014 -1.485 - 1.186 C 70% 0.015 -1.404 - 1.761
TT 2/256 (1) -0.058 -8.419 - 3.028 T 36% 0.088 -0.353 - 1.805
rs110402 0.453 rs242924 0.412
CC 102/256 (40) -0.070 -2.138 - 0.981 A 38% 0.086 -0.377 - 1.803
CT 118/256 (46) 0.012 -1.433 - 1.631 C 63% 0.007 -1.439 - 1.591
TT 36/256 (14) OXTR rs53576 0.086
rs7209436 0.408 G 69% 0.143 0.216 - 3.870
CC 104/256 (41) -0.66 -2.154 - 1.059 A 31% 0.021 -0.875 - 1,220
CT 119/256 (46) 0.022 -1.404 - 1.761 rs2254298 0.300
TT 33/256 (13) G 84% 0.048 -2.318 - 5.118
rs242924 A 16% -0.075 -1.803 - 0.458
AA 37/256 (14) 0.055 -0.908 - 2.183 0.412 BDNF rs6265 0.188
CA 118/256 (46) 0.087 -0.377 - 1.803 C 82% 0.040 -1.694 - 3.160
CC 101/256 (39) T 18% -0.095 -1.977 - 0.315
OXTR rs53576 0.086 rs2030324 0.978
GG 119/256 (46) A 55% 0.003 -1.291 - 1.357
AG 114/256 (45) 0.021 -0.875 - 1.220 G 45% 0.014 -1.038 - 1.286
AA 23/256 (9) -0.131 -3.690 - -0.050 rs11030101 0.676
rs2254298 0.300 A 57% 0.025 -1.084 - 1.599
GG 181/256 (71) T 43% 0.059 -0.630 - 1.655
AG 70/256 (27) -0.074 -1.803 - 0.458 rs11030102 0.899
AA 5/256 (2) -0.070 -5.714 - 1.568 C 74% 0.020 -1.686 - 2.295
BDNF rs6265 0.188 G 26% 0.029 -0.841 - 1.312
CC 175/256 (68) rs66866077 0.636
CT 68/256 (27) -0.090 -1.977 - 0.315 C 94%
TT 13/256 (5) -0.084 -3.869 - 0.741 T 6% -0.030 -1.913 - 1.172
rs2030324 0.978 rs75298795 0.124
AA 79/256 (31) C 88% -0.126 -6.856 - 0.067
GA 124/256 (48) 0.015 -1.038 - 1.286 T 12% -0.081 -2.078 - 0.473
GG 53/256 (21) 0.009 -1.342 - 1.524 rs76324918 0.755
rs11030101 0.676 T 94% -0.020 -6.833 - 4.982
AA 86/256 (34) C 6% 0.038 -1.153 - 2.129
TA 118/256 (46) 0.063 -0.630 - 1.655 rs77135086 0.665
TT 52/256 (20) 0.025 -1.161 - 1.670 A 92%
rs11030102 0.899 T 8% 0.027 -1.070 - 1.674
CC 144/256 (56) NPY rs16142 0.841
CG 92/256 (36) 0.028 -0.842 - 1.312 A 69% 0.036 -1.273 - 2.250
GG 20/256 (8) -0.005 -1.994 - 1.856 G 31% 0.025 -0.859 - 1.272
rs66866077 0.636 rs2023890 0.677
CC 225/256 (88) A 77% 0.042 -1.461 - 2.829
CT 31/256 (12) 0.030 -1.172 - 1.913 G 23% -0.025 -1.304 - 0.885
TT 0/256 (0) COMT rs4680 0.125
rs75298795 0.124 A 42% 0.102 -0.242 - 2.009
CC 201/256 (79) G 58% 0.116 -0.142 - 2.635
CT 49/256 (19) -0.78 -2.078 - 0.473 rs165599 0.875
TT 6/256 (2) 0.096 -0.724 - 5.908 G 39% -0.031 -1.366 - 0.843
rs76324918 0.755 A 61% -0.025 -1.740 - 1.188
TT 227/256 (89) rs2097603 0.193
CT 27/256 (11) 0.037 -1.153 - 2.129 A 66% -0.078 -2.546 - 0.647
CC 2/256 (1) 0.031 -4.311 - 7.139 G 34% 0.060 -0.586 - 1.564
rs77135086 0.665 MAOA rs73211189
AA 215/256 (84) C 82% 0.948
TA 41/256 (16) -0.027 -1.674 - 1.070 T 18% -0.006 -1.850 - 1.732
TT 0/256 (0) C (female) 86% 0.076 -2.953 - 7.498 0.658
Haplotypes 0.531 T (female) 14% 0.046 -1.276 - 2.194
C A A C C C T A 27/245 (11) 0.061 -0.957 - 1.059 rs909525
C A A G C C C A 7/245 (3) 0.039 -2.206 - 4.104 C 30% 0.106 -0.626 - 2.357 0.253
C A A G C C T A 25/245 (10) -0.056 -2.555 - 1.059 T 70%
C A A G T C T A 5/245 (2) -0.094 -2.206 - 4.104 T (female) 32% 0.200 0.342 - 5.411 0.071
C G T C C C T A 98/245 (40) C (female) 68% 0.113 -0.551 - 2.515
C G T C C C T T 37/245 (15) -0.013 -1.707 - 1.405 rs3788862
C G T C C T T A 33/245 (13) -0.028 -1.955 - 1.291 G 74% 0.424
T A A C C C T A 13/245 (5) -0.084 -3.904 - 0.857 A 26% 0.074 -0.924 - 2.180
NPY rs16142 0.841 G (female) 73% 0.186 0.168 - 5.818 0.060
AA 122/256 (48) A (female) 27% 0.158 -0.258 - 2.915
AG 108/256 (42) 0.025 -0.859 - 1.272 rs5905809
GG 26/256 (10) -0.021 -2.04 - 1.460 C 79% 0.437
rs2023890 0.677 G 22% 0.072 -0.999 - 2.298
AA 156/256 (61) C (female) 78% 0.031 -2.770 - 3.906 0.881
GA 83/256 (32) -0.024 -1.304 - 0.885 G (female) 22% 0.042 -1.233 - 1.986
GG 17/256 (7) -0.055 -2.951 - 1.165 rs5905823
COMT rs4680 0.125 A 76% 0.241
AA 45/256 (18) -0.034 -1.841 - 1.116 G 24% -0.109 -2.554 - 0.647
AG 127/256 (50) 0.108 -0.242 - 2.009 A (female) 76% 0.026 -3.406 - 4.606 0.162
GG 84/256 (33) G (female) 24% 0.167 -0.046 - 2.974
Table S2 - Univariate genotypic, haplotypic and allelic regression analysis results between the molecular markers and 
CD-RISC 10 scores 
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rs165599 rs142369182
GG 41/256 (16) C 100% - - -
GA 117/256 (46) -0.034 -1.740 - 1.188 0.875 T - - -
AA 98/256 (38) -0.002 -1.515 - 1.485 C (female) 99% - - 0.035
rs2097603 T (female) 1% -0.192 -12.906 - 0.494
AA 116/254 (46) rs142677545
AG 105/254 (41) 0.057 -0.604 - 1.547 0.198 C 97% 0.898
GG 33/254 (13) 0.117 -0.153 - 3.005 A 3% 0.012 -3.539 - 4.031
MAOA rs73211189 C (female) 95% 0.092 -4.315 - 13.770 0.578
C (male) 97/256 (38) 0.948 A (female) 5% 0.010 -2.566 - 2.876
T (male) 21/256 (8) -0.006 -1.850 - 1.732 rs147023114
CC (female) 102/256 (40) 0.658 C 92% - - 0.276
CT (female) 33/256 (13) 0.045 -1.276 - 2.194 T 4% -0.101 -3.799 - 1.095
TT (female) 3/256 (1) -0.061 -6.890 - 3.263 C (female) 94%
rs909525 T (female) 6% -0.067 -3.203 - 1.392 0.437
C (male) 35/256 (14) 0.106 -0.626 - 2.357 0.253 rs201583370
T (male) 83/256 (32) C 91% - - 0.578
TT (female) 14/256 (5) 0.071 T 9% 0.052 -1.690 - 3.016
CT (female) 59/256 (23) 0.112 -0.551 - 2.515 C (female) 93% 0.115 -2.997 - 14.747 0.263
CC (female) 65/256 (25) -0.132 -4.406 - 0.617 T (female) 7% 0.111 -0.828 - 3.751
rs3788862 SLC6A3 SLC6A3 - VNTR 0.150
G (male) 87/256 (34) 0.424 10R 66% -0.096 -2.869 - 0.454
A (male) 31/256 (12) 0.074 -0.924 - 2.180 9R 32% -0.159 -2.361 - -0.192
GG (female) 75/256 (29) 0.060 11R 1% -0.042 -6.155 - 3.074
GA (female) 52/256 (20) 0.154 -0.158 - 2.915 8R 1% 0.072 -1.721 - 6.307
AA (female) 11/256 (4) -0.101 -4.363 - 1.134 3R <1% 0.012 -7.130 - 8.715
rs5905809 SLC6A4 rs1042173 0.880
C (male) 93/256 (36) 0.437 A 58% -0.003 -1.426 - 1.368
G (male) 26/256 (10) 0.072 -0.999 - 2.298 C 42% 0.031 -0.869 - 1.403
CC (female) 85/256 (33) 0.881
GC (female) 44/256 (17) 0.040 -1.233 - 1.986
GG (female) 8/256 (3) -0.010 -3.402 - 3.018
rs5905823
A (male) 90/256 (35) 0.241
G (male) 28/256 (11) -0.109 -2.554 - 0.647
AA (female) 78/256 (30) 0.162
GA (female) 55/256 (21) 0.165 -0.046 - 2.974
GG (female) 5/256 (2) 0.037 -3.092 - 4.821
rs142369182
CC (male) 107/229 (47)
TT (male) 0/229 (0)
CC (female) 120/229 (52) 0.035
TC (female) 2/229 (1) -0.192 -12.906 - -0.494
TT (female) 0/229 (0)
rs142677545
C (male) 114/256 (45) 0.898
A (male) 4/256 (2) 0.012 -3.539 - 4.031
CC (female) 126/256 (49) 0.578
CA (female) 11/256 (4) 0.010 -2.566 - 2.878
AA (female) 1/256 (0) -0.089 -13.263 - 4.120
rs147023114
C (male) 108/256 (42) 0.276
T (male) 10/256 (4) -0.101 -3.799 - 1.095
CC (female) 122/256 (48) 0.437
CT (female) 16/256 (6) -0.067 -3.203 - 1.392
TT (female) 0/256 (0)
rs20158837
C (male) 107/256 (42) 0.578
T (male) 11/256 (4) 0.052 -1.690 - 3.016
CC (female) 121/256 (57) 0.263
CT (female) 16/256 (6) 0.108 -0.828 - 3.751
TT (female) 1/256 (0) -0.086 -13.056 - 4.230
Haplotypes 0.499
C?CCCCGTG 12/117 (10) 0.029 -2.658 - 3.552
CCCCCCACA 3/117 (3) -0.072 -7.461 - 3.188
CCCCCCGTA 49/117 (42)
CCCCCCGTG 35/117 (30) -0.008 -2.295 - 2.145
CCCCGCACA 14/117 (12) 0.169 -0.662 - 4.046
CCTCGCACA 3/117 (3) 0.035 -2.451 - 3.464
CCTTGCACA 1/117 (1) -0.049 -6.794 - 3.885
SLC6A3 SLC6A3 - VNTR 0.150
10R/10R 111/249 (45)
10R/9R 101/249 (41) -0.156 -2.361 - -0.192
9R/9R 29/249 (12) -0.083 -1.714 - 1.576
10R/11R 3/249 (1) -0.042 -6.155 - 3.074
10R/8R 4/249 (2) 0.072 -1.721 - 6.307
10R/3R 1/249 (0) 0.012 -7.130 - 8.715
SLC6A4 rs1042173 0.880
AA 86/255 (34)
CA 123/255 (48) 0.33 -0.869 - 1.403
CC 46/255 (18) 0.028 -1.181 - 1.772
Table S2 - Univariate genotypic, haplotypic and allelic regression analysis results between the molecular markers and 
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β 95% CI p-value β 95% CI p-value
0.098 -0.006 - 0.100 0.080 0.161 0.007 - 0.163 0.033
0.079 -0.266 - 1.550 0.165 0.212 0.151 - 1.365 0.015
0.178 0.198 - 1.157 0.006 -0.368 -0.328 - -0.123 0.000
-0.380 -0.298 - -0.149 0.000 MAOA rs73211189
FKBP5 rs1360780 C (male)
CC T (male) -0.031 -1.918 - 1.321 0.716
CT 0.33 -0.672 - 1.215 0.572 CC (female)
TT 0.005 -1.428 - 1.546 0.938 CT (female) 0.019 -1.289 - 1.675 0.797
C 0.016 -1.285 - 1.709 0.780 TT (female) -0.012 -4.735 - 3.992 0.866
T 0.033 -0.672 - 1.215 0.566 C (female) 0.019 -3.919 - 5.049 0.804
rs3800373 T (female) 0.020 -1.289 - 1.675 0.797
AA -0.044 -2.178 - 0.957 0.444 rs909525
CA 0.038 -0.627 - 1.254 0.512 C (male) 0.067 -0.822 - 1.920 0.429
CC T (male)
A 0.066 -0.675 - 2.523 0.256 TT (female)
C 0.039 -0.627 - 1.254 0.512 CT (female) 0.033 1.073 - 1.658 0.672
rs4713916 CC (female) -0.077 -3.284 - 1.065 0.315
AA 0.032 -1-184 - 2.136 0.573 C (female) 0.034 -1.073 - 1.658 0.672
GA -0.043 -1.300 - 0.582 0.453 T (female) 0.097 -0.824 - 3.628 0.215
GG rs3788862
A -0.044 -1.300 - 0.582 0.333 G (male)
G -0.056 -2.528 - 0.859 0.453 A (male) 0.057 -0.928 - 1.885 0.502
rs9296158 GG (female)
AA -0.001 -1.548 - 1.530 0.991 GA (female) 0.056 -0.866 - 1.879 0.467
GA 0.029 -0.714 - 1.191 0.623 AA (female) -0.025 -2.807 - 2.005 0.742
GG G (female) 0.057 -1.602 - 3.417 0.476
A 0.029 -0.714 - 1.191 0.623 A (female) 0.058 -0.866 - 1.879 0.467
G 0.028 -1.308 - 1.803 0.755 rs5905809
rs9470080 C (male)
CC G (male) 0.048 -1.067 - 1.921 0.572
CT 0.024 -0.748 - 1.142 0.682 CC (female)
TT 0.015 -1.282 - 1.663 0.799 GC (female) 0.007 -1.332 - 1.455 0.930
C 0.001 -1.1469 - 1.482 0.993 GG (female) 0.011 -2.548 - 2.940 0.888
T 0.024 0.748 - 1.142 0.682 C (female) -0.007 -2.981 - 2.712 0.926
CRHR1 rs4792887 G (female) 0.007 -1.332 - 1.455 0.930
CC rs5905823
CT -0.001 -1.184 - 1.157 0.982 A (male)
TT -0.075 -8.503 - 1.567 0.176 G (male) -0.109 -3.115 - 0.199 0.056
C 0.075 -1.652 - 8.561 0.184 AA (female)
T -0.001 -1.184 - 1.157 0.982 GA (female) 0.121 -0.214 - 2.371 0.101
rs110402 GG (female) 0.024 -2.827 - 3.923 0.749
CC A (female) 0.023 -2.88' - 3.941 0.759
CT 0.046 -0.980 - 1.734 0.585 G (female) 0.123 -0.214 - 2.371 0.101
TT 0.023 -1.188 - 1.573 0.784 rs142369182
C 0.032 -0.980 - 1.734 0.585 CC (male)
T 0.022 0.796 - 1.165 0.712 TT (male)
rs7209436 CC (female)
CC 0.017 -1.278 - 1.562 0.844 TC (female) 0.111 -9.208 - 1.449 0.152
CT 0.046 -1.020 - 1.767 0.598 TT (female)
TT C (female)
C 0.031 -1.020 - 1.767 0.598 T (female) -0.111 -9.208 - 1.449 0.152
T 0.028 -0.738 - 1.202 0.638 rs142677545
rs242924 C (male)
AA -0.012 -1.512 - 1.227 0.838 A (male) 0.051 -2.383 - 4.484 0.546
CA 0.024 -0.782 - 1.181 0.689 CC (female)
CC CA (female) 0.017 -2.076 - 2.609 0.822
A 0.024 -0.782 - 1.181 0.689 AA (female) -0.105 -12.829 - 2.073 0.156
C 0.030 -0.997 - 1.681 0.615 C (female) 0.110 -2.119 - 13.408 0.153
OXTR rs2254298 A (female) 0.017 -2.076 - 2.609 0.822
GG rs147023114
AG -0.023 -1.206 - 0.783 0.676 C (male) -0.084 -3.350 - 1.100 0.319
AA -0.080 -5.547 - 0.823 0.145 T (male)
G 0.073 -1.104 - 5.405 0.194 CC (female)
A -0.024 -1.206 - 0.783 0.676 CT (female) -0.071 -2.917 - 0.989 0.331
BDNF rs6265 TT (female)
CC C (female)
CT -0.084 -1.771 - 0.220 0.126 T (female) -0.071 -2.917 - 0.989 0.331
TT 0.115 -4.137 - 0.120 0.058 rs20158837
C 0.073 -0.761 - 3.468 0.209 C (male)
T -0.089 -1.771 - 0.220 0.126 T (male) 0.048 -1.514 - 2.740 0.569
rs2030324 CC (female)
AA CT (female) 0.080 -0.882 - 3.041 0.278
GA 0.036 -0.725 - 1.316 0.569 TT (female) 0.103 -12.722 - 2.116 0.160
GG -0.013 -1.390 - 1.130 0.839 C (female) 0.125 -1.248 - 14.013 0.100
A 0.042 -0.757 - 1.608 0.479 T (female) 0.082 -0.882 - 3.041 0.278
G 0.033 -0.725 - 1.316 0.569
Variables
Age
SHS scores
Mental Health scores
Variables
Age
Gender
SHS scores
Mental Health scores
Table S3 - Multivariate genotypic, haplotypic and allelic regression analysis results for the remaining markers with the 
CD-RISC 10 scores 
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rs11030101 Haplotypes
AA C?CCCCGTG -0.005 -2.785 - 2.620 0.952
TA 0.057 -0.533 - 1.471 0.357 CCCCCCACA -0.033 -5.611 - 3.651 0.676
TT -0.010 -1.344 - 1.151 0.879 CCCCCCGTA
A 0.056 -0.638 - 1.769 0.355 CCCCCCGTG 0.006 -1.873 - 1.982 0.955
T 0.054 -0.533 - 1.471 0.357 CCCCGCACA 0.144 -0.602 - 3.483 0.165
rs11030102 CCTCGCACA 0.028 -2.156 - 2.976 0.752
CC CCTTGCACA 0.012 -4.299 - 4.998 0.882
CG 0.082 -0.243 - 1.644 0.145 R²
GG 0.012 -1.495 - 1.854 0.833
C 0.034 -1.213 - 2.253 0.555
G 0.085 -0.243 - 1.644 0.145
rs66866077
CC
CT -0.22 -1.627 - 1.080 0.691
TT - - -
C
T 0.022 -1.080 - 1.627 0.691
rs75298795
CC
CT -0.075 -1.889 - 0.346 0.175
TT 0.055 -1.453 - 4.411 0.321
C -0.084 -5.301 - 0.800 0.147
T -0.078 -1.889 - 0.346 0.175
rs76324918
TT
CT 0.019 -1.190 - 1.681 0.736
CC -0.006 -5.307 - 4.761 0.915
C 0.019 -1.190 - 1.681 0.736
T 0.011 -4.674 - 5.711 0.844
rs77135086
AA
TA 0.037 1.604 - 0.790 0.503
TT - - -
A
T 0.037 -0.790 - 1.604 0.503
Haplotypes
C A A C C C T A 0.064 -0.706 - 2.382 0.286
C A A G C C C A 0.010 -2.551 - 3.022 0.868
C A A G C C T A -0.015 -1.804 - 1.394 0.801
C A A G T C T A -0.077 -5.476 - 1.055 0.184
C G T C C C T A
C G T C C C T T 0.008 -1.278 - 1.462 0.895
C G T C C T T A -0.013 -1.600 - 1.280 0.827
T A A C C C T A -0.105 -4.012 - 0.189 0.074
NPY rs16142
AA
AG 0.066 -0.397 - 1.494 0.254
GG 0.034 -1.979 - 1.067 0.556
A 0.074 -0.536 - 2.544
G 0.067 -0.397 - 1.494
rs2023890
AA
GA 0.004 -0.924 - 0.989 0.946
GG -0.049 -2.607 - 1.005 0.383
A 0.051 -1.045 - 2.713 0.383
G 0.004 -0.924 - 0.989 0.946
COMT rs4680
AA -0.040 -1.731 - 0.873 0.517
AG 0.045 -0.633 - 1.365 0.471
GG
A 0.042 -0.633 - 1.365 0.471
G 0.074 -0.431 - 2.021 0.203
rs165599
GG
GA -0.045 -1.640 - 0.911 0.574
AA 0.004 -1.275 - 1.345 0.958
G -0.048 -1.368 - 0.568 0.416
A -0.033 -1.640 - 0.911 0.574
rs2097603
AA
AG 0.010 -0.865 - 1.035 0.860
GG 0.071 -0.523 - 2.255 0.220
A -0.061 -2.143 - 0.664 0.300
G 0.020 -0.783 - 1.114 0.732
SLC6A4 rs1042173
AA
CA -0.002 -1.013 - 0.974 0.969
CC 0.033 -0.944 - 1.642 0.595
C -0.002 -1.1013 - 0.974 0.969
A -0.035 -1.597 - 0.859 0.555
R² 0.239
0.297
Table S3 - Multivariate genotypic, haplotypic and allelic regression analysis results for the remaining markers with the 
CD-RISC 10 scores (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BDNF Haplotypes: rs6265-rs2030324-rs11030101-rs11030302-rs66866077-rs75298795-rs76324918-rs77135086 
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